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Abstract
The Effects of Resveratrol on Oxidative Stress and Muscle Atrophy
Janna Renee Jackson

Increases in oxidative stress and apoptosis are associated with skeletal muscle atrophy
caused by prolonged periods o f muscle disuse and also as p art o f the nor mal ag ing
process. The loss of muscle size and strength with age is known as sarcopenia and has
detrimental implications to the quality of life for elderly individuals. Although the causes
of sarcopenia and disuse-mediated atrophy are largely unknown, an increased oxidant
load has the p otential t o negatively i mpact both muscle m ass and f unction by directly
causing oxidative damage to tissue constituents and also via the initiation of the intrinsic
mitochondrial apop totic pat hway. Due t o i ts m ulti-nucleated c ellular s tructure, s keletal
muscle is an exception with regard to the linear relationship between apoptosis and cell
death. Apoptosis in skeletal muscle results in the potential loss of both myonuclei and/or
muscle pr ecursor c ells ( i.e. s atellite c ells). This i s o f p articular s ignificance i n s keletal
muscle g iven t hat s keletal m uscle i s a pos t-mitotic t issue an d t hus i t’s onl y m eans of
regeneration r ests w ith its a bility t o ac tivate an d pr opagate s atellite c ells. T herefore,
oxidative stress may potentially contribute to the process of muscle atrophy via a dual fold m echanism, by both di rectly ox idizing t he nuc leic ac ids, l ipids and pr oteins t hat
make u p t he muscle t issue and by creating a m ore f avorable ap optotic environment
leading to an eventual loss of myonuclei.
Resveratrol ( 3,5,4,trihydroxystilbene) i s a n aturally oc curring pol yphenol found i n over
seventy plant species that has been shown to have anti-oxidant, anti-apoptotic and antiaging pr operties. R esveratrols’ capacity t o en hance t he e ndogenous a nti-oxidant
system, upr egulate ant i-apoptotic pr oteins and i mprove m itochondrial function,
presumably t hrough the activation o f t he N AD+ dependent d eacetylase S irtuin1,
suggests t hat s upplementation with r esveratrol m ay pot entially protect skeletal muscle
from t he d etrimental ef fects of increases i n oxidative s tress and t he s ubsequent
increase in apoptotic signaling that are present in many atrophic conditions. Therefore,
the major g oals o f this di ssertation ar e t o further u nderstand t he i nterplay bet ween
oxidative stress and s keletal muscle atrophy and t o evaluate the efficacy of resveratrol
as a counter measure to both mitochondrial-induced oxidative stress and apoptosis.
The first s tudy us ed hindlimb s uspension ( HLS) as a m odel o f di suse at rophy as i t i s
known t o elicit muscle atrophy, oxidative stress and apoptosis in skeletal muscle. The
aim o f t he i nvestigation w as t o analyze t he capacity o f r esveratrol administration at a
moderate dose o f 12.5mg/kg/day for 2 1 da ys to at tenuate ox idative s tress, apopt osis
and muscle f orce l oss f ollowing 14 days of H LS i n y oung and aged r ats. T he s tudy
yielded m ixed r esults. Resveratrol administration effectively r educed oxidative s tress
and s ubsequently oxidative dam age in m uscles f rom ag ed a nimals. F urthermore,
resveratrol adm inistration at tenuated t he r elative l oss of m uscle mass as a r atio o f
animal body w eight i n g astrocnemius muscles f rom ag ed ani mals; how ever, des pite
reductions in apoptotic signaling in aged muscles, resveratrol administration was unable

to mitigate a poptosis as measured by D NA fragmentation. M oreover, r esveratrol
administration had no protective effect on gastrocnemius muscles from young animals
with regard to oxidative or apoptotic indices. Based on these results resveratrol has the
potential t o b e a n e ffective therapeutic agent t o t reat m uscle functional d ecrements
associated w ith di suse i n ag ed i ndividuals, v ia i mproving t he r edox s tatus as sociated
with these conditions.
The second hal f o f the dissertation f ocuses on the c apacity o f l ong-term dietary
supplementation with resveratrol to protect a gainst ag ing-induced oxidative stress a nd
to enhance mitochondrial signaling, and t hus stem t he pr ogression o f s arcopenia i n
aged skeletal m uscle. In t his s tudy m iddle-aged ( 18mo) C57BL/6 m ice were
supplemented w ith a diet c ontaining . 05% trans-resveratrol f or 1 0 m onths until they
reached senescence (28mo). Gastrocnemius, pl antaris an d v astus l ateralis muscles
from s upplemented animals w ere c ompared for an ti-oxidant enzyme content and
activities, oxidant load, oxidative damage, mitochondrial integrity a nd mass, as well as
muscle function indices with muscles from young and middle-aged animals receiving a
control di et. Resveratrol specifically upr egulated t he c apacity o f the m itochondrial
isoform of s uperoxide di smutase ( MnSOD) and c oncomitantly dec reased hy drogen
peroxide concentrations. This was paralleled by reductions in lipid peroxidation, but not
protein oxidation in muscles from supplemented animals. Despite reductions in oxidant
load and lipid peroxidation resveratrol, supplementation was unable to confer protection
against s arcopenia. F urthermore, plantaris m uscles from s upplemented ag ed animals
did not show enhanced resistance to muscle fatigue, nor an increase in maximal force
production.
Taken as a whole these results suggest that resveratrol may be most effective when
used as a pharmacological pre-conditioner to help confer resistance to oxidative
damage under perturbations that are known to increase oxidative stress. Specifically,
resveratrol may be an effective therapeutic agent to improve the redox status of aged
skeletal muscle and therefore allow for improved adaptation and recovery following
chronic illness and/or injuries during which the capacity of the endogenous antioxidant
system may be overwhelmed in aged individuals. Gaining clearer insight into the
molecular signaling pathways involved in aging and disuse muscle atrophy is
paramount in developing nutritional and/or pharmacological interventions to minimize
protein loss and attenuate the functional decrements associated with atrophic
conditions.
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Specific Aims
With advanced age there is a progressive loss of skeletal muscle mass, termed
sarcopenia (32). The frailty and loss of function associated with sarcopenia puts the
elderly at an increased risk of falls and subsequent injury, resulting in a marked
decrease of their quality of life (6; 17). Furthermore, sarcopenia represents a
tremendous financial burden; the estimated direct healthcare costs attributable to
sarcopenia in the United States in the year 2000 was $18.5 billion (18). The causative
factors of sarcopenia are multi-factorial and include a progressive denervation of muscle
fibers (11), an altered hormonal milieu (35), and an increase in protein degradation and
a concomitant decrease in protein synthesis, resulting in a net loss of contractile
proteins (19; 29). Moreover, sarcopenia can be compounded by reductions in dietary
intake (31) and activity levels (10) often associated with advanced age.
Both advanced age and disuse are associated with atrophy and an increased
production of reactive oxygen species (ROS) in skeletal muscle (24; 25; 28), leading to
an augmented oxidant-load. When an increase in pro-oxidant production exceeds an
organisms’ capacity to buffer them, via a complex coordination of the endogenous
antioxidant defense system, oxidative stress occurs. Oxidative stress, left unchecked
over time leads to the oxidation, and thus damage, of cellular macromolecules,
including lipids (26), nucleic acids (15) and proteins (2; 9; 16). The progressive oxidative
assault on cellular organelles is believed to be a main contributor to the aging process
(13) and is thought to be responsible for many of the pathologies associated with aging,
including genomic instability, mitochondrial dysfunction and chronic inflammation (13;
14).
xii

Oxidative stress is believed to be a common underlying mechanism potentiating
many of the factors leading to muscle loss with aging (12; 28), of particular interest is
the redox sensitive apoptotic pathway (37). Oxidative stress is upstream of apoptotic
signaling in muscle cells (34) and results in the initiation of the intrinsic mitochondrial
apoptotic pathway. Due to its multi-nucleated cellular structure, skeletal muscle is an
exception with regard to the linear relationship between programmed cell death and
apoptotic signaling. Instead, apoptosis in skeletal muscle results in a loss of myonuclei
and consequent fiber atrophy (1).
Antioxidant supplementation has been shown to be an effective counter measure
to combat oxidative stress in a wide variety of tissue types and conditions (7; 28) and it
is speculated that this might be an approach to reduce muscle wasting associated with
disuse (33) and aging (7). Dietary supplementation with the polyphenol, resveratrol,
exerts beneficial effects not only through its’ ability to directly scavenge free radicals (3;
5), but also by its’ capacity to modulate the signal transduction and gene expression of
several pathways regulating cellular proliferation (30), mitochondrial biogenesis (20; 36),
metabolism (12; 13; 28), and survival. The efficacy of acute resveratrol administration
has been established for several pathological conditions (4; 20; 27); however, the use of
chronic resveratrol supplementation as a counter-measure to combat oxidative stressinduced muscle loss and sarcopenia has not been established.
The long-term goal of this study is to characterize the mechanisms responsible for the
progression and pathogenesis of sarcopenia and disuse-induced muscle loss and to
use this information to develop strategies for the prevention and treatment of muscle
loss with aging. The main objectives of the project were: (1) to characterize the
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endogenous antioxidant defense system in young and old skeletal muscles exposed to
hindlimb suspension (HLS); (2) to determine the ability of resveratrol to reduce oxidative
stress associated with both aging and skeletal muscle disuse via an enhancement of
the endogenous antioxidant defense system; (3) to evaluate the potential of long-term
resveratrol supplementation to attenuate the detrimental effects of aging in skeletal
muscle via reductions in pro-oxidant production by enhancing cellular mitochondrial
content, integrity and function; (4) to characterize the relationship between oxidative
stress and myonuclear apoptosis contributing to skeletal muscle atrophy.
The central hypothesis of the project is that enhancing the muscle’s endogenous
antioxidant defense system and promoting mitochondrial biogenesis will reduce
oxidative stress, consequently reducing muscle cell apoptosis. Attenuation of
myonuclear apoptosis will result in a reduction of skeletal muscle atrophy associated
with both disuse and advanced age. Our central hypothesis is based on data from our
laboratory and published data from other laboratories, suggesting that sarcopenia and
muscle atrophy occurs concurrently with a reduction in mitochondria content and
increases oxidative stress (12; 22; 23). Resveratrol may act to both reduce oxidative
stress and improve mitochondria biogenesis (4; 8; 20; 21). The rationale for this project
is that a delineation of the potential importance of resveratrol to reduce oxidative stress
and mitochondrial dysfunction potentially leading to attenuation of apoptosis and the
improved regulation of muscle mass during aging would potentially provide
opportunities for intervention, or prevention, of the development of sarcopenia in aged
individuals.
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Specific Aim 1: To evaluate the efficacy of resveratrol administration to
ameliorate muscle atrophy associated with muscle disuse by reducing oxidative
stress and apoptotic signaling.
To address aim 1, indices of oxidative stress and the content of mitochondriaassociated apoptotic proteins were assessed in the gastrocnemius muscles of young
adult and old rats subjected to resveratrol treatment during acute muscle disuse
induced by HLS. Additionally, muscle function was assessed, pre and post-HLS, to
determine the efficacy of resveratrol to preserve muscle mass and function following
disuse.
•

Hypothesis 1.1: Hindlimb suspension will increase oxidative stress in
gastrocnemius muscles; Resveratrol administration will improve the redox
status of these muscles by increasing their endogenous antioxidant defense
systems.

•

Hypothesis 1.2: The gastrocnemius muscles from old HLS animals will
exhibit greater increases in oxidative stress than gastrocnemius muscles from
young HLS animals; Resveratrol administration will attenuate this increase.

•

Hypothesis 1.3: Hindlimb suspension will increase apoptotic signaling in
gastrocnemius muscles from both young and old animals; Resveratrol
administration will reduce apoptotic signaling in these muscles.

•

Hypothesis 1.4: Resveratrol administration will improve muscle function in
the gastrocnemius muscles from HLS animals by reducing oxidative stress
and subsequently reducing myonuclear apoptosis-induced atrophy, leading to
maintenance of muscle force following HLS.
xv

Specific Aim 2: To determine the ability of long-term resveratrol supplementation
to counteract the detrimental effects of aging on skeletal muscle mass, function,
and oxidant load.
To address aim 2 select antioxidant enzyme capacities, oxidative stress indices,
mitochondrial-associated signaling proteins and muscle mass and function (force and
fatigability) were evaluated in the hindlimb muscles of old mice subjected to long-term
resveratrol supplementation. The dietary supplementation with 0.05% trans-resveratrol
began at middle-age (18 months old) mice and continued through old age (28 months
old). Sirtuin1 (Sirt1) were measured because it is potentially activated by resveratrol.
Therefore, Sirt1 may have a key role in regulating mitochondrial-associated changes in
response to long-term supplementation.
•

Hypothesis 2.1: Long-term resveratrol supplementation will reduce oxidative
stress and consequently oxidative damage in aged skeletal muscle, there by
slowing the progression of sarcopenia by helping to maintain the muscle mass of
old mice.

•

Hypothesis 2.2: Long-term resveratrol supplementation will prevent the ageassociated decline in force production in hindlimb muscles of old mice by
providing a more favorable muscle redox environment.

•

Hypothesis 2.3: Long-term resveratrol supplementation will activate Sirt1 and
in turn will promote mitochondrial biogenesis and improve mitochondrial
membrane integrity, thus improving resistance to fatigue in skeletal muscles of
old mice.
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Chapter 1: Background and Significance

1.1: Sarcopenia; An overview of the consequences and underlying mechanisms:

Loss of muscle strength and muscle wasting are characteristic of aging and are
caused by both a loss of muscle fibers and atrophy of the remaining fibers (33; 113).
Age associated loss of muscle mass and function is termed sarcopenia (113).
Sarcopenia is a ubiquitous problem facing the elderly and is characterized by marked
frailty, impaired mobility and an increased risk of injury (58; 113). The combination of
these factors leads to a severe reduction in the quality of life for older individuals and
presents an ever increasing burden on our already taxed healthcare system. In the year
2000, it was estimated that a 10% reduction in the prevalence of sarcopenia would
result in savings of $1.1 billion per year in U.S. healthcare costs (58). The percentage of
the U.S population in their seventh and eighth decade of life is increasing at a faster
rate than at any other time in U.S. history (1), underscoring the importance of finding
effective countermeasures to combat age-related pathologies, including sarcopenia.
Although it is known that sarcopenia results in ~40% reduction in skeletal muscle mass
by the age of 80 (77), the mechanisms underlying this severe muscle atrophy have not
been completely elucidated. However, age-related increases in pro-oxidant production
and the resultant oxidative stress associated with this increase are thought to be
important mediators of the mechanisms triggering sarcopenia and the aging process as
a whole (45). One pathway known to be activated by oxidative stress (137) and also
implicated in the progression of sarcopenia (6) is the programmed cell death, or
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apoptotic pathway. Apoptosis results in cell death for mono-nucleated cells and a loss of
nuclei in multi-nucleated cells, such as skeletal muscle (6). Since the number of nuclei
within a muscle fiber is proportional to the size of the fiber, the loss of myonuclei is a
key factor in skeletal muscle atrophy caused by a wide variety of muscle wasting
conditions (5; 6), including denervation (2; 126), disuse (38; 128), immobilization (142)
and advanced age (6). Furthermore, aged individuals must contend with the additive
effect of the basal incidence of oxidative stress and apoptotic signaling that are inherent
with advanced age, compounded by the fact that aging potentiates apoptosis during
disuse, resulting in an enhanced atrophic environment (116; 130).

1.2 Oxidative stress and the process of aging:

Aging is an inevitable process that results in detrimental structural and functional
changes starting at the subcellular level and eventually affecting the integrity and
function of tissues, organs and whole systems within animals. Although the pathologies
associated with aging are well documented (84), the exact mechanisms underlying
these pathologies are a constant source of debate. One theory that has gained
popularity over the past two decades, is “the mitochondrial theory of aging”, originally
presented by Dr. Denham Harmon in 1956. The theory is based on the idea that with
advanced age there is an increase in free radical production from mitochondria due to
reductions in the organelles integrity and function and that these free radicals oxidize
and subsequently damage biomolecules (45; 46; 124). Thus, the accumulation of
irreversible damage to lipids (94), proteins (52) and nucleic acids (49) drives the aging
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process. The accrual of damage induced by oxidative stress can ultimately lead to cell
death in various tissues and cell types, including muscle stem cells (39; 62; 62).
Furthermore, oxidative stress is positively correlated with skeletal muscle atrophy
induced by aging (39), denervation (90), disuse and immobilization (69; 71; 100). These
atrophic stimuli are associated with concomitant increases in lipid peroxidation ,
glutathione oxidation, protein carbonyl formation (133), free iron content (50), xanthine
oxidase levels (50) and nucleic acid damage (50; 133), which can lead to genomic
instability and altered gene expression. Compounding the effect of increased prooxidant production and the associated macromolecule damage seen with advanced age
(39) and muscle disuse (129) are the inherent alterations in the endogenous
antioxidant defense systems that occur with aging (95; 103). Although there is an
incongruence in the literature as to whether the endogenous antioxidant system activity
increases or decreases with aging, there is an overwhelming amount of literature
suggesting that despite increases in enzymatic activity and/or content of the antioxidant
enzymes, the antioxidant defense system in aged individuals can become more easily
overwhelmed in situations that potentiate oxidant production leading to oxidative stress
and consequent damage (94; 116; 129).

1.3 The endogenous anti-oxidant system:

Antioxidant enzymes and compounds are present in organisms as simple as
single-celled yeasts (57), to the most complex of organisms, humans (95). Their
ubiquitous presence underscores the importance of protecting oneself from the harmful
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effects of pro-oxidants. The endogenous anti-oxidant system is composed of a complex
coordination of enzymes and small molecules, whose sole responsibilities are to keep
the levels of pro-oxidants in check. Antioxidant enzymes function by converting reactive,
and thus toxic, pro-oxidants into less reactive forms, in a series of enzymatic reactions
resulting in more inert biological molecules. An example of this type of chain reaction is
exemplified by the coordination of two enzymes, superoxide dismutase (SOD) and
catalase in the stepwise removal of the highly reactive superoxide anion (O2•). The
superoxide anion is a harmful free radical that is generated in the mitochondria when
electrons escape the electron transport chain and react with molecular oxygen, to form
O2•- (14). The protonated form (HO2•-) can initiate lipid peroxidation (44; 79) and lead to
the formation of radical species such as peroxynitrite (ONOO-) and the hydroxyl radical
(OH•-) (44). Therefore, limiting the production and enhancing the removal of O2•- via
SOD is a key aspect in limiting the potential downstream oxidation of biomolecules (87).
Superoxide dismutase has several isoforms that all catalyze the same reaction in
different subcellular locations; the dismutation of O2• - into the less reactive pro-oxidant
hydrogen peroxide (H2O2) (11; 87). Catalase,(located in both the cytosol and in microperoxisomes in skeletal muscle) (20; 108), then further converts H2O2 into O2 and
water. Alternatively, H2O2 can be reduced by other peroxidases, such as glutathione
peroxidase, a very abundant enzyme found in the cytosol. The glutathione redox cycle
reduces H2O2 by the continual interplay between glutathione reductase and glutathione
peroxidase. Glutathione peroxidase catalyzes the reaction in which glutathione donates
an electron to reduce H2O2 and glutathione reductase regenerates glutathione via a
NADH- dependent reaction, thus this cycle is self-sustaining and extremely beneficial in
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the prevention of oxidative stress (11). Additionally, there are other non-enzymatic
molecules present in biological systems that function as anti-oxidants, such as vitamin
C and vitamin E (102). These small molecules exert their antioxidant capabilities by
acting as electrons donors, and thus effectively reducing pro-oxidants before they can
cause oxidative damage. They can also play a role in the repair of oxidized
biomolecules. (102). Overall, the endogenous antioxidant defenses system is very
effective in protecting cellular components against oxidation; however, under
extenuating circumstances, in which pro-oxidant production increases dramatically, or is
present for prolonged periods of time, the system can become overwhelmed, leading to
oxidative stress and the associated downstream effects (11).

1.4 Mitochondrial dysfunction; A source of reactive oxygen species with aging:

Age-related mitochondrial alterations underlie a wide variety of diseases such as
diabetes (81), neurodegeneration (122) and sarcopenia (17). The premise behind this
relationship is that with advanced age there are more dysfunctional mitochondria
present within a cell (80). These defective mitochondria contain “leaky” electron
transport chains and thus more pro-oxidants are produced leading to oxidative stress
(17; 49). The process is cyclic, with more mitochondrial uncoupling, there are more prooxidants present to further damage vulnerable membrane phospholipids (49; 94) and
perhaps more importantly oxidatively damage mtDNA, which unlike nuclear DNA, is
without the protection of chromatin condensation and histones (26). Thus, damaged
mtDNA can lead to a further decrease in the quality and quantity of mitochondria within
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a cell, potentiating an oxidizing environment. Although mitochondria are not the sole
source of ROS within a cell, they are routinely viewed as the principle site of superoxide
generation, which is the primary source of damaging ROS within muscle cells (55; 56).

Figure 1.1- Mitochondria mediated ROS generation.

Mitochondrial derived superoxide generation increases with advanced age (91).
Additionally, mitochondria have recently been shown to be the primary source of ROS
within muscle precursor cells (143) (146). The potential for ROS to damage satellite
cells is of particular concern in a post-mitotic tissue like skeletal muscle, as satellite cells
6

represent the only mechanism for muscle repair, adaptation and regeneration; thus the
only mechanism available to combat sarcopenia (114; 123). Further evidence linking
mitochondrial dysfunction and skeletal muscle atrophy is the negative association
between muscle fiber size and the content of dysfunctional mitochondria (48; 88).

1.5 Oxidative stress and muscle atrophy:

Oxidative stress is associated with skeletal muscle atrophy caused by a variety of
underlying conditions (89; 136). During extended periods of oxidative stress there is an
eventual loss of cellular integrity mediated by the oxidation of lipids (94; 118), proteins
(29; 89) and nucleic acids (50), promoting a cycle of increased pro-oxidant production,
and thus increased oxidative damage, which limits both the cellular repair system and
the enzymatic antioxidant defense system (39). The exact mechanisms by which
oxidative stress acts as a potentiator of muscle atrophy are largely unknown, however,
several relationships between oxidative stress and atrophy have been postulated (39;
101). Specifically, skeletal muscle atrophy is characterized by an overall reduction in
protein synthesis and/or a concomitant increase in protein catabolism resulting in a net
protein loss (10; 63). Oxidized proteins are preferentially targeted by the 20S
proteasome (60) and are subsequently degraded via proteolysis (60). However,
severely oxidized proteins are poorly recognized by the proteasome system and thus
can aggregate and lead to an accumulation of dysfunctional proteins (42; 95; 132).
Additionally, several key signaling pathways responsible for regulating muscle
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precursor cell proliferation, differentiation and survival are redox sensitive, including the
forkhead family of transcription factors (FOXOs) (141; 145) and nuclear factor-ĸB
(NFĸB) (76; 115; 136). Therefore, in an oxidizing environment these proteins have the
potential to promote cell cycle arrest and decrease the proliferation of satellite cells,
potentiating muscle atrophy. Furthermore, key mitogen-activated kinases (MAPKs),
involved in the cellular stress response, are positively regulated by oxidative stress (31;
137) and when activated, act as upstream activators of the apoptotic pathway (118),
which is associated with skeletal muscle atrophy. Clearly, the potential is there for
oxidative stress to negatively impact the proliferation and differentiation capacity of
satellite cells, the muscles only source of regenerative potential (24; 76; 140), has it
therefore could influence muscle size and function.

1.6 Oxidative stress and muscle function:

Given that oxidative stress is positively correlated with muscle atrophy (32; 39;
129), it is likely negatively associated with muscle force production (21; 23; 53; 107).
Furthermore, increased pro-oxidant production and/or an attenuated capacity to buffer
these pro-oxidants, may result in reductions in muscle function beyond the linear
relationship between cross-sectional area and muscle force generation (22; 53; 107)
due to alterations of neural and/or metabolic factors (22).
This reduced functional capacity may be particularly true in aged skeletal muscle,
where the increase in pro-oxidant production can overwhelm the endogenous anti-
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oxidant defense system, leading to cellular damage, increased muscle frailty and thus a
decreased functional capacity (39; 49).
Specifically, increases in oxidative stress have the potential to depress muscle
specific force (21; 99), alter myofilament function as a result of loading (70; 72) and
perturb calcium handling induced by muscle contractions leading to calpain activation
(35; 36; 97; 125). Additionally, it is possible that oxidative stress could alter muscle
function by impeding recovery from injury (64) and other pathological conditions, given
that muscle precursor cells are sensitive to oxidative stress (86; 104; 140) .

1.7 Oxidative stress and apoptosis; the mitochondrial link:

Figure 1.2- Mitochondria as mediators of oxidative stress and apoptosis.
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Myonuclei undergo apoptosis in many muscle wasting conditions including, but
not limited to, advanced age (6), disuse (128) and denervation (92; 126). Likewise,
these conditions are also associated with increases in oxidative stress (101),
presumably generated through mitochondrial dysfunction, given the importance that the
mitochondria play in maintaining cellular integrity via ROS production and the regulation
of the apoptotic pathway (3; 8; 139). Mitochondria house several proteins, which in
times of cellular stress, are released in to the cytosol through the mitochondrial
transition pore (mtPTP) in the outer mitochondrial membrane (8; 66; 118). These
proteins include several modulators of the apoptotic signaling pathway, including
apoptosis inducing factor (AIF), Cytochrome c, endonuclease G, and smac/diablo which
initiate a cascade of proteolytic events that converge on the nucleus leading to the
fragmentation of DNA and ultimately cell death (8; 66). Regulation of the mtPTP
opening is mediated via the B-cell lymphoma-2 (Bcl-2) family of proteins (47; 66), which
contains both anti and pro-apoptotic members. Specifically, the pro-apoptotic member,
Bax, is responsible for the mitochondrial transition pore channel formation via homooligermization and subsequent insertion into the outer mitochondrial membranes
resulting in pore formation (see Figure 1.2) (47; 66). Conversely the channel is
negatively regulated by the anti-apoptotic Bcl-2 protein, which acts to inhibit mtPTP
formation by dimerizing with Bax (8; 66), thus preventing Bax from translocating and
inserting into the membrane.
One pathway that directly links oxidative stress and apoptosis starts with the
phosphorylation and subsequent activation of two members of the redox sensitive
MAPK pathway; c-jun kinase (JNK) and p-38 (121). Both JNK and p38 are activated by
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apoptosis signaling kinase 1 (ASK-1) (18), a kinase upstream of the mitochondria (18).
In a reducing environment ASK-1 remains inactive due to its dimerization with reduced
thioredoxin (TRX) an anti-oxidant compound that functions in a very similar manner to
the glutathione redox system and effectively reduces peroxides, such as H2O2 (27;
150). However, in an oxidizing environment TRX is oxidized and can no longer bind
ASK-1, leaving the kinase free to phosphorylate its downstream targets, which include
both JNK and p38 (27; 121; 150). Both Bax and Bcl-2 have multiple phosphorylation
sites (30; 147; 148), which when phosphorylated confer conformational changes that
can either promote, or inhibit their ability to regulate the mtPTP opening and
consequently apoptosis (65). JNK and p-38 have been shown to each have the
capability to phosphorylate both Bcl-2 and Bax (65). Bcl-2 phosphorylation causes the
protein to lose its affinity for Bax, preventing Bcl-2 from sequestering Bax in the cytosol
and thus abrogating its anti-apoptotic potential (43). Conversely, the phosphorylation of
Bax causes a conformational change that exposes its N-terminus and promotes its
ability to insert into the outer mitochondrial membrane and initiate apoptosis (65)
It should be noted that these pathways, although well characterized in vitro, have
been very hard to elucidate in vivo and to date no study exists (to the author’s
knowledge), characterizing the actual, not theoretical, role that the ASK-1 pathway may
play in myonuclear apoptosis in skeletal muscle. The lack of direct evidence is likely
due, in part, to the lack of effective antibodies for use in rodent skeletal muscle given
that ASK-1 gene expression is well characterized in skeletal muscle (13). ASK-1 protein
levels do not appear to be present in high concentrations in skeletal muscle, making
elucidating the role that ASK-1 may play in the oxidative stress apoptotic continuum
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hard to clarify. Although direct manipulations of the signaling that occurs in skeletal
muscle in response to oxidative stress is difficult to ascertain, taken as a whole the
literature shows evidence that a causal relationship between an oxidant mediated
stressor and the initiation of both the extrinsic (inflammatory mediated) and intrinsic
(mitochondrial mediated) apoptotic pathways does exist.

1.8 Countermeasures to oxidative stress:

Gaining clearer insight into the molecular signaling pathways involved in aging
and disuse-mediated muscle atrophy is paramount in developing nutritional and/or
pharmacological interventions to minimize protein loss and attenuate the functional
decrements associated with atrophic conditions. To date, numerous studies have been
undertaken to evaluate the efficacy of various compounds, including antioxidants
(vitamin E & C) (9; 124; 133), enzyme antagonists (allopurinol) (85) and other signaling
modulators (NFk-B inhibitors) (59), in improving physiological and functional outcomes
following atrophic stimuli. The results of these interventional studies vary from showing
no beneficial effects of supplementation interventions (37) , to showing promising
protective effects with regard to muscle mass (9; 124; 149) and function (9; 85).
Although the potential seems clear for antioxidant and other signal modifying
compounds to provide protection against oxidative stress by acting as free radical
scavengers, antioxidant enzyme enhancers, or promoters of mitochondrial biogenesis,
there are many variables to consider. The bioavailability of a compound, the chosen
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route of administration and its metabolism within an animal (82), may alter their efficacy
as anti-atrophic countermeasures, potentially explaining the lack of congruency in the
literature (51).
If in fact one believes that mitochondria are the primary source of ROS within a
cell and that their integrity and content are directly related to the aging process (45; 49),
then an ideal countermeasure to both aging and disuse-associated oxidative stress and
subsequent muscle atrophy would be a compound with direct free radical scavenging
capabilities, the capacity to upregulate the endogenous antioxidant defense system and
directly improve mitochondrial content and function, leading to a reduction in pro-oxidant
production. Fortunately, it seems such a compound exists; resveratrol.

1.9 Resveratrol, an antioxidant and activator of Sirtuin 1:

Resveratrol (3,5,4,trihydroxystilbene) is a naturally occurring polyphenol found in
over seventy plant species, including grapes, peanuts and mulberries. It belongs to the
stilbene family of phytoalexins, which are anti-microbial compounds produced in plants
in response to bacterial, or fungal infections (15). Resveratrol has gained popularity
over the past decade due to its potent anti-oxidant and anti-aging properties (83; 96;
109). Recent studies have shown resveratrol to improve the outcomes of pathological
conditions ranging from cancer (16; 95; 112; 138; 149), chronic inflammation (34; 105;
111) and neurodegenerative diseases (111). Specifically, resveratrol has been shown to
mediate cardiomyocyte survival following simulated hypoxia/reperfusion by upregulating both the antioxidant thioredoxin and the anti-apoptotic protein Bcl-2 (27).
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Resveratrol also stimulated glutathione synthesis in alveolar epithelial cells exposed to
cigarette smoke extract (68; 95). Additionally, several recent studies demonstrated the
ability of resveratrol to specifically induce the transcription of two key antioxidant
enzymes, catalase (68; 73; 95; 117) and MnSOD (68; 95; 109; 110; 117), both in vitro
and in vivo.
With regard to skeletal muscle, resveratrol administration has effectively
attenuated protein degradation in murine myotubes treated with proteolysis-inducing
factor and attenuated muscle atrophy, in vivo, in a mouse model of cachexia (149).
Furthermore, acute dietary resveratrol supplementation attenuated lipid peroxidation
and improved the redox status, (quantified by the reduced to oxidized glutathione ratio),
in aged murine skeletal muscle exposed to a repetitive loading protocol (117). Likewise,
acute resveratrol administration was able to attenuate lipid peroxidation and reduce
H2O2 concentrations in skeletal muscles from aged animals undergoing extended
unloading (54). In an in vitro model of anti-viral therapy, the addition of resveratrol to
primary myoblasts isolated from human quadriceps muscles which were treated with
protease inhibitors, the hallmark treatment of those individuals infected with the Human
Immunodeficiency Virus (HIV), resveratrol completely ablated the increase in ROS that
is known to occur following protease inhibitor treatments. Moreover, supplementation
with a combination of a low dose of resveratrol and coenzyme Q improved both the
inflammatory status and morphological profile in quadriceps muscles from dystrophic
mice (98). The protective effect of resveratrol with regard to the aforementioned
parameters is significant because muscle regeneration is the one of the key deficiencies
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with muscular dystrophies and therefore it is possible that resveratrol may enhance the
capacity of muscle to regenerate under pathological conditions.
Despite the fact that resveratrol has the biochemical capacity to directly
scavenge free radicals due to its phenol ring structure and in fact, resveratrol has
repeatedly been shown to be a potent scavenger of ROS in numerous cell types
exposed to pro-oxidants (16; 61; 83; 110). However, its rapid first pass metabolism in
mammals and thus relatively low bioavailability (28; 40; 82), may limit its role as a direct
ROS scavenger in vivo. Consequently, in vivo, the various health benefits of resveratrol
can more likely be attributed to its ability to activate the NAD dependent deacetylase,
silent mating type information regulation homolog1, or sirtuin1 (Sirt1) (4; 74).
Sirt1 has been shown to play a role in a variety of important physiological
functions including gluconeogenesis, energy expenditure, lipid oxidation, mitochondrial
biogenesis and the regulation of oxidative stress and survival across a wide array of cell
types (67; 74; 93; 144; 150). Sirt1 effectively protects certain mammalian cells from
apoptosis by deaceytylating and thus inactivating p53 (41), furthermore, Sirt1
specifically protects against Bax-induced apoptosis through activation of the Bax
transcriptional inhibitor Ku70 (7). Additionally, Sirt1 upregulates the transcription of both
MnSOD and catalase (41), further showcasing its potential as a protective mechanism
against oxidative stress. Sirt1 is also activated with exercise (134) and under conditions
of nutrient deprivation (19; 145), underscoring its effectiveness as a caloric restriction
mimetic. This is significant because both exercise (127; 131) and caloric restriction (12;
19; 75) are proven countermeasures to combat both oxidative stress and myonuclear
apoptosis. Therefore, we would expect resveratrols’ ability to activate Sirt1, to effectively
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reduce muscle loss during both disuse and aging. In a recent study, resveratrol
stimulated muscle precursor cell proliferation in a Sirt1 dependent manner (106), further
expanding the mechanisms by which resveratrol supplementation may improve muscle
mass and function by enhancing muscles regenerative capacity, which has been shown
to be augmented with aging (24; 25) and in certain pathological conditions.
Furthermore, and perhaps most importantly, Sirt1 is a powerful regulator of PPARγ coactivator (PGC-1α) (135), which is considered to be the master regulator of
mitochondrial function (78). PGC-1α is decreased during atrophic conditions (119; 120),
but muscle specific overexpression of PGC-1α confers protection against both
denervation and fasting-induced skeletal muscle atrophy (120). Therefore, the ability of
Sirt1 to promote mitochondrial biogenesis, including structural components of the
electron transport chain, ATPases, oxidative enzymes and the induction of MnSOD,
provides compelling evidence with regard to resveratrols’ potential ability to protect
skeletal muscle from oxidative stress-induced damage and thus myonuclear apoptosis
(see figure 1.3).
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Figure 1.3- Potential mechanism(s) of resveratrol mediated protection.

1.10 Conclusion:
As of 2008 the United States Department of Health and Human Services projects
that the number of individuals over the age of 65 will double in the next 20 years,
making sarcopenia a debilitating and costly reality for an ever increasing percentage of
our population. A relationship between increases in oxidative stress and decreases in
muscle mass and function clearly exists, thus it is increasingly imperative that effective
therapies are found to alleviate oxidative stress and thus improve the quantity and
quality of skeletal muscle in elderly individuals. Overall, the reliance of skeletal muscle
viability on proper muscle function skeletal muscle viability highlights the importance of
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promoting mitochondrial biogenesis and conserving mitochondrial membrane integrity
as important countermeasures to reduce skeletal muscle atrophy associated with disuse
and aging. Sirt1 activation is positively associated with an increased resistance to
oxidative stress and apoptosis, likely due to its capacity to promote mitochondrial
biogenesis. Resveratrol is a potent activator of Sirt1 and thus shows promise as an
effective therapy to lessen mitochondrial-induced oxidative stress and apoptosis. There
has been limited animal research conducted regarding the protective effects of
resveratrol supplementation on skeletal muscle. Given the inherent differences between
cell culture models and whole animals models, it is important to elucidate the specific
signaling pathways of resveratrol, in vivo, to further our understanding of its’ capacity to
protect against skeletal muscle atrophy.
The major goals of this research are to further understand the interplay between
oxidative stress and skeletal muscle atrophy and to evaluate the efficacy of resveratrol
as a countermeasure to both mitochondrial-induced oxidative stress and apoptosis. It is
hypothesized that with skeletal muscle disuse and advanced age there will be an
increase in both oxidative stress and a concomitant decrease in muscle mass and
function. Resveratrols’ capacity to upregulate the endogenous anti-oxidant defense
system, increase mitochondrial biogenesis and thus enhance cell viability, makes it an
ideal candidate to combat oxidative stress and sarcopenia (see Figure 1.4). Thus it is
hypothesized that resveratrol will improve muscle mass and function with both disuse
and aging-induced muscle atrophy. It is expected that the results of the current study
will help to further our understanding of the usefulness of dietary supplements as
effective countermeasures to alleviate the mechanism(s) underlying sarcopenia.
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Figure 1.4- Working model of resveratrol mediated protection.
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ABSTRACT
Hindlimb suspension (HLS) elicits muscle atrophy, oxidative stress, and apoptosis in
skeletal muscle. Increases in oxidative stress can have detrimental effects on muscle
mass, function and can potentially lead to myonuclear apoptosis. Resveratrol is a
naturally occurring polyphenol possessing both anti-oxidant and anti-aging properties.
To analyze the capacity of resveratrol to attenuate oxidative stress, apoptosis and
muscle force loss were measured following 14 days of HLS. Young (6 mo) and old (34
mo) rats were administered either 12.5mg/kg/day of trans-resveratrol, or 0.1%
carboxymethylcellulose for 21days, including 14 days of HLS. HLS induced a
significant decrease in plantarflexor isometric force, but resveratrol blunted this loss in
old animals. Resveratrol increased gastrocnemius catalase activity, MnSOD activity,
and MnSOD protein content following HLS. Resveratrol reduced hydrogen peroxide and
lipid peroxidation levels in muscles from old animals after HLS. Caspase 9 abundance
was reduced and Bcl-2 was increased, but other apoptotic markers were not affected by
resveratrol in the gastrocnemius muscle after HLS. The data indicate that resveratrol
has a protective effect against oxidative stress and muscle force loss in old HLS
animals; however, resveratrol was unable to attenuate apoptosis following HLS. These
results suggest that resveratrol has the potential to be an effective therapeutic agent to
treat muscle functional decrements via improving the redox status associated with
disuse.
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Introduction
Both advanced age and skeletal muscle disuse are associated with atrophy and
an increased production of reactive oxygen species (ROS) in skeletal muscle (27),
leading to an augmented oxidant-load. Oxidative stress occurs when an increase in
oxidant production exceeds an organisms’ capacity to buffer them, via a complex
coordination of the endogenous antioxidant defense system. During extended periods of
oxidative stress there is an eventual loss of cellular integrity mediated by the oxidation
of lipids (29), proteins (26) and nucleic acids (18), promoting a cycle of increased
oxidant production. This results in elevated levels of oxidative damage, which limits both
the cellular repair system and the enzymatic antioxidant defense system (14). The exact
mechanisms by which oxidative stress acts as a potentiator of muscle atrophy are
largely unknown, however, several links between oxidative stress and atrophy have
been postulated (32).
Oxidative stress is upstream of apoptotic signaling in muscle cells in vitro (46),
and results in the initiation of the intrinsic mitochondrial apoptotic pathway. Of particular
interest in the current study was to determine if redox sensitive apoptotic signaling (49)
could be suppressed by resveratrol administration during experimentally-induced
muscle disuse. This is an important area of inquiry, because myonuclei undergo
apoptosis during muscle disuse (42,44), and this is thought to contribute to fiber
atrophy, especially in aging muscles (2,3). Likewise, muscle disuse is associated with
increases in oxidative stress (1,27), presumably mediated through mitochondrial
dysfunction via ROS production and the regulation of the apoptotic pathway (17,44).
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Antioxidant supplementation has been shown to be an effective counter measure
to combat oxidative stress in a wide variety of tissue types and conditions (7,33), and it
is speculated that this might be an approach to reduce muscle wasting associated with
both disuse (40) and aging (7). Resveratrol (3,5,4,trihydroxystilbene) is a naturally
occurring polyphenol found in over seventy plant species, including grapes, peanuts
and mulberries (5). Resveratrol has gained popularity over the past decade due to its
potent anti-oxidant and anti-aging properties (24,36). Recent studies have shown
resveratrol to have positive effects on the outcomes of pathological conditions ranging
from cancer (6) chronic inflammation (19) and neurodegenerative diseases (37).
Specifically, resveratrol has been shown to mediate cardiomyocyte survival following
simulated hypoxia/reperfusion by up regulating both the antioxidant thioredoxin and the
anti-apoptotic protein Bcl-2 (4,10), thus underscoring its potential to act as both an
antioxidant and anti-apoptotic compound. Likewise in a recent study in PC12 cells
exposed to hydroxynonenal , an oxidizing byproduct of lipid peroxidation, pretreatment
with resveratrol decreased the amount of the pro-apoptotic Bax protein, decreased
caspase 3 activity and increased the amount of anti-apoptotic Bcl-2 protein, conferring
complete protection against oxidative stress and apoptotic signaling (41). Additionally,
recent data suggest that resveratrol induces the transcription of two key antioxidant
enzymes, catalase (9,21) and MnSOD (36,39). Furthermore, a recent study in our
laboratory found acute dietary supplementation with resveratrol to effectively reduce
indices of oxidative stress in repetitively loaded skeletal muscles, presumably through
the upregulation of antioxidant enzymes including MnSOD, an important mitochondrial
antioxidant in muscles from both young and old animals (39). The efficacy of acute
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resveratrol administration has been established for several pathological conditions;
however, the use of chronic resveratrol administration as a counter-measure to prevent
muscle loss caused by disuse has not been established.
Therefore, the primary aim of this study was to evaluate the efficacy of a daily
moderate dose of resveratrol to ameliorate oxidative stress and subsequent myonuclear
apoptosis induced by skeletal muscle disuse in both young and old animals. In the
present investigation, it was hypothesized that resveratrol would reduce the indices of
hindlimb suspension (HLS)-induced oxidative stress in skeletal muscle and thus lessen
the potential for downstream apoptotic signaling and subsequent muscle atrophy
stemming from myonuclear loss. Furthermore, it was hypothesized that resveratrol
administration would preserve muscle function following HLS both by preservation of
muscle mass during the HLS protocol and by providing a more favorable redox
environment.
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METHODS

Animals. All experiments were conducted on young adult (6mo) and old (34mo)
Fischer Brown Norway x 344 male rats. The animals were obtained from the NIA colony
house at Harlan (Indianapolis, IN) and kept in pathogen-free conditions at ~20°C, on a
reversed twelve-hour light cycle. All experimental procedures carried approval from the
Institutional Animal Use and Care Committee from West Virginia University School of
Medicine. The animal care standards followed the recommendations for the care of
laboratory animals as advocated by the American Association for Accreditation of
Laboratory Animal Care (AAALAC) and fully conformed to the American Physiological
Society's "Guiding Principles for Research Involving Animals and Human Beings.”

Hindlimb Suspension. The hindlimb suspension technique employed in the current
study is a modification of the technique originally described by Morey-Holton and
Globus (25). This method allows for an even load distribution on the tail, permits the
animals with 360° of movement around the cage, and assures that the forelimbs
maintain contact with a grid floor, allowing the animals to move and access food and
water freely as previously described (44,45). Briefly, orthopedic tape was applied along
the proximal one-third of the tail then placed through a wire harness that is attached to a
swivel placed at the top of a specially designed hindlimb suspension cage. Sterile gauze
was then wrapped around the orthopedic tape and was subsequently covered with a
thermoplastic material, which formed a hardened cast (Vet-Lite; Veterinary Specialty
Products, Boca Raton, FL). The distal tip of the tail was examined daily to verify that
the procedure did not occlude blood flow to the tail. The suspension height was
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adjusted to prevent the animal’s hindlimbs from touching any supportive surface, with
care taken to maintain a suspension angle that did not exceed 30°. Weight bearing
control animals were allowed to ambulate freely in their cages.

Experimental Protocol. Prior to commencement of the experimental protocol, all
animals went through a 7-day acclimation period, which included the daily oral gavage
of 1mL of distilled H2O. Animals were hindlimb suspended (HLS) for 14 days. Seven
days preceding suspension and continuing throughout the suspension protocol, all
animals received either 1mL of 0.1% Carboxymethylcellulose dissolved in deionized
water, or 1mL of trans-resveratrol suspended in 1mL of 0.1% Carboxymethylcellulose.
Resveratrol was purchased from Orchid Pharmaceuticals (India). The resulting
solutions were administered via oral gavage at a dose of 12.5mg/kg/day, for a total of
21 days. This dosage was chosen to provide a low to moderate daily dose of resveratrol
that would have the potential to be therapeutic, but would not be high enough to be proapoptotic as can be seen with higher doses of resveratrol (13). Age-matched, nonsuspended animals served as weight-bearing controls (Figure 1).

Refer to Figure 1

Force Analysis. Pre and post-HLS force measurements were assessed in anesthetized
animals using a custom built rat dynamometer (8,38). The rat was placed supine on a
heated X–Y positioning table of the rodent dynamometer, and anesthesia was induced
with 5% isoflurane. Anesthesia was maintained in the animals over the duration of the
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experiment with 2% isoflurane. The left foot was secured to the footplate at an ankle
angle of 90° and the knee was braced to ensure that forces were transmitted to the
footplate. Vertical forces applied to the aluminum sleeve fitted over the dorsum of the
foot were translated to a load cell transducer in the load cell fixture on the footplate.
Platinum stimulating electrodes (Grass Medical Instruments, Quincy, MA) were inserted
subcutaneously to span the tibial nerve in the popliteal fossa. The maximal isometric
force of the plantar flexor muscle group was evaluated by stimulating the tibial nerve
using supramaximal square wave pulses at 100Hz for a duration of 1000 ms using a
SD9 stimulator (Grass Medical Instruments, Quincy, MA). The voltage used in these
experiments was 10% greater than the voltage required to obtain maximal force
production. Maximal force was determined off-line via custom Labview based software
(8). The maximal forces for three isometric contractions were averaged for each data
point. These in vivo force records were obtained before and after HLS. The percent in
force loss with HLS was obtained by comparing the average pre-HLS for record with the
post-HLS force record.

Muscle preparation. Immediately following the last contraction, the gastrocnemius
muscle was dissected from both limbs muscle, weighed and snap frozen. To eliminate
the possibility that the isometric muscle function tests could acutely affect
measurements of oxidative stress, the gastrocnemius muscle from the limb that was not
evaluated for muscle function (the right limb) was used for analysis of oxidative enzyme
activities, oxidative stress, and apoptotic indices. The animals were then euthanized by
removing the heart.
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Protein Isolation. Seventy-five micrograms of gastrocnemius muscle from each animal
was homogenized in RIPA buffer (1% Triton x-100, 150mM NaCl, 5mMEDTA, 10mM
Tris; pH: 7.4) for assessment of protein expression, caspase activity and cell death as
measures by an ELISA. For all oxidative enzyme activity assays and/or redox status
assessments muscle samples were homogenized in either PBS, or the kit specific buffer
provide by the manufacturer. Muscle samples were homogenized in 500 μL of the
appropriate ice-cold lysis buffer using a mechanical homogenizer. Muscle homogenates
were centrifuged at 1000 x g for 5 minutes at 4°C. The resulting supernatant was
collected and divided into two portions and frozen at –80°C either with, or without a
protease inhibitor cocktail containing 104 mM 4-[2-aminoethyl]-benzenesulfonyl fluoride
hydrochloride, 0.8 mM aprotinin, 2 mM leupeptin, 4 mM bestatin, 1.5 mM pepstatin A,
and 1.4 mM E-64 (Sigma-Aldrich, St. Louis, MO) added to it. Protein concentrations for
each sample were determined in duplicate using the DC Protein Assay kit (Bio-Rad,
Hercules, CA).

Catalase Activity. The activity of catalase was determined in gastrocnemius muscle
homogenates using a commercially available kit (# 707002 Cayman Chemical
Company, Ann Arbor, MI) as described previously in our laboratory (39). The samples
were read on a microplate reader (DYNEX technologies, Chantilly VA) at an
absorbance of 520nm. All analyses were measured in duplicate and the samples were
normalized to µg of protein per μL of muscle homogenate.
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Manganese Superoxide Dismutase (MnSOD) and Copper-Zinc Superoxide
Dismutase (CuZnSOD) Activity Levels. Superoxide dismutase activity was measured
in gastrocnemius muscle homogenate using a colorimetric enzyme activity kit (Cayman
Chemical Company Ann Arbor, MI) following the manufacturer’s guidelines. Both total
SOD activity and MnSOD activity were obtained. CuZnSOD activity was determined by
subtracting MnSOD activity from total SOD activity. The assay was performed with
slight modifications to the manufacturer’s directions. All analyses were measured in
duplicate and the samples were normalized to µg of protein per μL of muscle
homogenate as described previously by our laboratory (14). Briefly, muscle samples
were homogenized in 20mM HEPES buffer, containing 1mM EGTA, 210mM mannitol,
and 70 mM sucrose, and centrifuged at 1000 x g for 10 min. 50 µl of the resulting
supernatant was incubated either with, or without, 12 mM potassium cyanide to inhibit
CuZnSOD and extracellular SOD activity. The sample absorbance was measured at
450 nm using a 96-well plate reader (Dynex Tech., Chantilly VA., USA).

Immunoblots. The protein content of the oxidative enzymes Catalase, CuZnSOD, and
MnSOD and the apoptotic markers Bax and Bcl-2 were assessed in gastrocnemius
muscle homogenates. Either β-tubulin or GAPDH was used as loading controls.
Although most blots were probed with β-tubulin, GAPDH was used as a loading control
for blots in which we probed for Bax, because we had intended on also measuring
apoptosis inducing factor (AIF) on the same blot, because AIF and Bax run at different
molecular weights. However, AIF runs at a similar molecular weight as β-tubulin (data
not shown) and therefore, we could not use β-tubulin as the loading control for these
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blots. Thirty to forty micrograms of protein were loaded into each well of a 4%–12%
gradient polyacrylamide gel (Invitrogen, Carlsbad, CA) and separated by routine sodium
dodecyl sulfate–polyacrylamide gel electrophoresis (SDS–PAGE) for 1.5hrs at 20°C,
followed by transfer to a nitrocellulose membrane for 70min at 35V. All membranes were
blocked in 5% nonfat milk (NFM) for 1 hour at room temperature. The membranes were
then incubated overnight at 4°C in the appropriate primary antibodies. Primary
antibodies were diluted in Tris-buffered saline, with 0.1% Tween-20 (TBST) and 10%
sodium azide. Membranes were then washed in 0.05% TBST followed by incubation in
the appropriate dilutions of secondary antibodies (diluted in 5% NFM in TBST)
conjugated to horseradish peroxidase. The signals were developed using a
chemiluminescent substrate (Lumigen TMA-6; Lumigen, Southfield, MI) and visualized
by exposing the membranes to x-ray films (BioMax MS-1; Eastman Kodak). Digital
records were captured by a Kodak 290 camera, and protein bands were quantified using
1D analysis software (Eastman Kodak). Bands were quantified as optical density x band
area and expressed in arbitrary units relative to the loading control bands.

Hydrogen Peroxide (H2O2) Content. H2O2 content in gastrocnemius muscle
homogenate was measured using a fluorescent assay according to the manufacturer’s
recommendations (Cell Technology, Mountain View, CA). Briefly, 50 μL of control,
unknown muscle samples, or H2O2 standards were mixed with 50 μL of the reaction
cocktail provided in the kit and added to each well to initiate the reaction. The plate was
then incubated in the dark for 10 minutes at room temperature. The intensity of the
fluorescent signal was detected using an excitation wavelength of 530 nm and an
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emission wavelength of 590 nm. A linear regression was performed by plotting the
resultant florescent intensities from the known standards and subsequently the
unknown samples were fit to the corresponding linear equation. All analyses were
measured in duplicate and the samples were normalized to µg of protein per μL of
muscle homogenate as determined by the DC Protein Assay Kit (Bio-Rad Hercules,
CA).

Lipid Peroxidation. Malondialdehyde (MDA) and 4-hydroxyalkenals (HAE) were
assessed with reagents from Oxis International (BIOXYTECH LPO-586). Approximately
100 mg of gastrocnemius muscle was homogenized in 750 μL of ice cold buffer
containing phosphate-buffered saline (20 mM, pH 7.4) and 5 μL of 0.5 M butylated
hydroxytoluene in acetonitrile per 1 mL of tissue homogenate. Assay reagents were
added following the manufacturer's recommendations. Briefly, the muscle homogenate
was centrifuged at 3000 x g at 4°C for 10 minutes, and subsequently the supernatant
was used to assess lipid peroxidation. The sample was incubated in the proper
reagents at 45°C for 60 minutes, and then centrifuged at 15,000 x g for 10 minutes. The
absorbance of the resulting supernatant was read at 586 nm. All analyses were
measured in duplicate and the samples were normalized to µg of protein per μL of
muscle homogenate as determined by the DC Protein Assay Kit (Bio-Rad Hercules,
CA).

Caspase Activity. The proteolytic activity of caspase 9 and 3 were assessed with a
fluorometric activity assay using the commercially available substrates; AC VDVADAFC and AC-DEVD-AFC (Alexis Biochemical, San Diego, CA) respectively. Briefly,
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50μL of caspase activity buffer (50 mM PIPES, 0.1 mM EDTA, 10% glycerol, 1 mM
DTT) was added to each well of a 96-well fluorescent microplate (Thermo Fisher
Scientific). Subsequently, 50μL of gastrocnemius muscle homogenate and 10μL of the
appropriate caspase substrate (1mM) were added to each well. Caspase activity was
determined by measuring fluorescent intensity using a fluorescent microplate reader at
an excitation of 400nm and an emission of 505nm. The microplate was incubated at
37°C for 2-hours with caspase activity determined by subtracting the OD readings at
time 2-hour from the initial reading, to eliminate any background fluorescence that was
not mediated by caspase activity. All analyses were measured in duplicate and the
samples were normalized to µg of protein per μL of muscle homogenate as determined
by the DC Protein Assay Kit (Bio-Rad Hercules, CA).

Cell-Death ELISA Assay. A commercially available ELISA kit (Cell Death Detection
ELISA, Roche Diagnostics, Indianapolis, IN) was used to quantify DNA fragmentation in
gastrocnemius muscle homogenate. Briefly, the wells of a 96-well plate were coated
with a primary anti-histone mouse monoclonal antibody. Following the addition of 100
μL of muscle homogenate, a secondary anti-DNA mouse monoclonal antibody coupled
to peroxidase was added to each well. The substrate, 2,2’-azino-di-(3ethylbenzthiazoline sulfonate) (ABST) was used to photometrically determine the
amount of peroxidase retained in the immunocomplex. The colorimetric change of each
well was determined at a wavelength of 405nm using a Dynex MRX plate reader and
computer software (Revelation, Dynatech Laboratories, CA). All analyses were
measured in duplicate and the samples were normalized to µg of protein per μL of
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muscle homogenate as determined by the DC Protein Assay Kit (Bio-Rad Hercules,
CA). The resulting OD was recorded as the apoptotic index (OD405 / mg protein). This
assay measures DNA fragmentation in myonuclei, satellite cells, and non-muscle cell
nuclei. However, because DNA fragmentation as determined by this ELISA is directly
proportional to TUNEL identification of apoptotic muscle nuclei in old rat muscle after
hindlimb suspension (30), the data obtained in the ELISA assay are a reasonable
indicator of the apoptotic environment in skeletal muscle of the experimental animals.

Statistics. Statistical analyses were performed using the SPSS 13.0 software package
(SPSS, Chicago, IL). A multiple analysis of variance was used to examine differences
between age, suspension and supplementation. Tukey’s post-hoc analyses were
performed to protect against type 1 errors. Where appropriate, student t-tests were
implemented to evaluate paired comparisons. Statistical significance was accepted at p
≤ 0.05. Data are reported as mean ± standard error of the mean.
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RESULTS

Body Weight. Resveratrol was unable to suppress the body weight loss associated
with HLS. All animals were weighed prior to the experimental protocol and immediately
before euthanasia (Table 1). Older animals were significantly heavier than young
animals (460 ± 38g vs. 548 ± 39g; p ≤ 0.05). Young vehicle control suspended (YVCS)
animals lost ~15% of their body weight during the 14-day suspension protocol, while old
vehicle control suspended (OVCS) animals lost ~ 13.5% of their body weight during the
14-day suspension protocol. There was no significant effect of resveratrol administration
on the body weight of young vehicle control (YVC), YVCS, old vehicle control (OVC)
or old OVCS animals. There was no significant difference between the percent of total
body weight lost during the 21-day experimental protocol when comparing groups of
HLS animals (Table 1).

Refer to Table 1

CuZnSOD Enzyme Activity and Protein Content. Both aging and HLS significantly
increased the activity of CuZnSOD in gastrocnemius muscles, but this was not affected
by resveratrol. CuZnSOD activity was significantly increased in gastrocnemius muscles
from old animals compared to gastrocnemius muscles from young animals (0.083 ±
.007 vs. 0.055 ± 0.002 U/ml/mg; p ≤ 0.05), resveratrol administration did not alter
CuZnSOD further with aging (Figure 2A). HLS increased CuZnSOD activity in
gastrocnemius muscles from both young and old animals regardless of resveratrol
administration. There was no change in CuZnSOD protein content in the gastrocnemius
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muscle from any treatment, or age group (Figure 2B). Resveratrol increased CuZnSOD
activity (Figure 2A) but not CuZnSOD content (Figure 2B) in control muscles from old
animals.

Refer to Figure 2

MnSOD Enzyme Activity and Protein Content. MnSOD activity was increased by
aging and resveratrol in control muscles of old animals. While HLS decreased MnSOD
activity, MnSOD activity in resveratrol-treated muscles after HLS was elevated over the
control muscles of old rats. Relative to young animals, MnSOD activity was 78% greater
(p ≤ 0.05) in vehicle control old animals and resveratrol administration further increased
MnSOD activity in old non-suspended animals by an additional ~20% (p ≤ 0.05),
(Figure 2C). HLS had no effect on MnSOD activity in young animals; however, HLS
significantly reduced MnSOD activity in old vehicle control animals by approximately
23% (20.3 ± 1.7 vs. 14.6 ± 0.98 U/ml/mg, p ≤ 0.05), resveratrol administration was able
to completely abolish the decrease in activity seen with HLS. There was no aging effect
on MnSOD protein content in non-suspended animals, however, similar to activity
levels, MnSOD protein content was significantly reduced in old suspended animals
(Figure 2D). Furthermore, resveratrol administration mitigated the effects of HLS on
MnSOD protein content.

Catalase Activity and Protein Content. Resveratrol increased catalase activity in
control muscles of old rats. Catalase activity significantly increased with aging in
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gastrocnemius muscles from both vehicle control animals and animals that were
administered resveratrol (p ≤ 0.05) as compared to young adult animals (Figure 2E).
Furthermore, gastrocnemius muscles from old non-HLS animals who received
resveratrol had higher catalase activity than old non-HLS vehicle controls (6.14 ± 0.61
vs. 8.56 ± 0.81 mU activity /mg protein, p ≤ 0.05). HLS had no significant effect on
catalase activity in either age group, and resveratrol administration showed no further
increase in catalase activity following HLS. Catalase protein content increased with HLS
in both young and old animals (Figure 2F). Resveratrol further augmented catalase
protein abundance in young HLS animals and old non-suspended animals.

Hydrogen Peroxide (H2O2) Concentrations. H2O2 was assessed in gastrocnemius
muscle homogenates as an indicator of oxidant load during aging and HLS. Aging and
HLS increased H2O2 levels in gastrocnemius muscles of old rats, but resveratrol
suppressed this increase in H2O2 content. H2O2 levels were ~3 fold higher (p ≤ 0.05) in
gastrocnemius muscles from old animals when compared to gastrocnemius muscles
from young animals (Figure 3A). There was a significant interaction of age and
suspension, (p ≤ 0.05). HLS had no significant effect on H2O2 content in young
gastrocnemius muscles, regardless of resveratrol administration. Resveratrol
administration significantly (p ≤ 0.05) reduced H2O2 levels in gastrocnemius muscles
from old control animals and old-HLS animals by 23% and 16% respectively, when
compared to gastrocnemius muscles from old vehicle control and old vehicle controlHLS animals, (p ≤ 0.05). There was still a significant increase in H2O2 content following
HLS in gastrocnemius muscles from both vehicle control (2.29 ± 0.06 vs. 2.55 ± 0.05
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μmols H2O2 /μg protein; p ≤ 0.05) and resveratrol administered animals (1.77 ± 0.16 vs.
2.14 ± 0.06μmols H2O2 /μg protein; p ≤ 0.05), however there was no difference in the
H2O2 content between gastrocnemius muscles from old vehicle control and old
resveratrol-HLS animals (2.29 ± 0.06 vs. 2.14 ± 0.05μmols H2O2 /μg protein).

Refer to Figure 3

Lipid Peroxidation. Malondialdehyde (MDA) and 4-hydroxyalkenals (HAE) were
assessed in whole muscle homogenates as indicators of oxidative damage, specifically
as markers of muscle lipid peroxidation. Both aging and HLS increased lipid
peroxidation in the gastrocnemius muscle, but this was suppressed by resveratrol. HLS
significantly increased lipid peroxidation by ~55 % (p ≤ 0.05) in young animals
regardless of resveratrol administration (Figure 3B). Lipid peroxidation was increased in
old animals compare to their young counterparts (0.171 ± .02 vs. 0.079 ± 0.01 µM
[MDA/HAE]/mg protein; p ≤ 0.05). There was no further significant increase in MDA and
HAE levels in old animals that underwent HLS; however, gastrocnemius muscles from
old animals that were administered resveratrol had significantly reduced levels of lipid
peroxidation compare to old vehicle control suspended animals (0.199 ± 0.02 vs. 0.159
± 0.01 µM [MDA/HAE]/mg protein; p ≤ 0.05), this represented a 20% decrease in MDA
and HAE levels in old resveratrol suspended animals.
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Bax and Bcl-2 Protein Contents. Aging was generally associated with increased proapoptotic protein signaling in the gastrocnemius muscle. The pro-apoptotic Bax protein
levels in gastrocnemius muscles from old animals increased ~1.8 fold (p ≤ 0.05),
regardless of resveratrol administration (Figure 4A). There was no further effect of HLS,
or resveratrol administration, in either age group. Similarly, Bcl-2 protein levels
increased 2.6 fold (p ≤ 0.05) in gastrocnemius muscles from old vehicle control animals
when compared to their young counterparts (Figure 2B). Resveratrol administration
further increased Bcl-2 protein content in gastrocnemius muscles from old resveratrol
non-HLS animals by ~20% (p ≤ 0.05), when compared to gastrocnemius muscles from
non-HLS vehicle control animals. HLS significantly increased Bcl-2 protein content in
gastrocnemius muscles from old vehicle control-HLS animals by ~18.6% (p ≤ 0.05),
when compared to gastrocnemius muscles from non-HLS vehicle control rats. There
was no effect of HLS on Bcl-2 content in gastrocnemius muscles from old animals. HLS
caused significant increases in Bcl-2 protein content in gastrocnemius muscles from
both young vehicle control (36%, p ≤ 0.05) and young resveratrol administered (29%, p
≤ 0.05) animals. There was no effect of resveratrol administration in gastrocnemius
muscles from young animals.

Refer to Figure 4

Caspase 9 and Caspase 3 Activities. Caspase 9 and 3 activities were measured via
fluorometric assays as an assessment of the contribution of mitochondrial mediated
caspase dependent apoptotic signaling. Resveratrol blunted only the aging and HLS-
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induced increase in caspase-9 activity in muscles of old rats. Both caspase 9 (Figure
4C) and caspase 3 (Figure 4D) activities were increased in gastrocnemius muscles from
old animals, when compared to their young counterparts. Neither caspase 9 nor
caspase 3 were altered by HLS, or resveratrol administration, in the muscles of young
animals. There was no effect of resveratrol administration on caspase 9 activity in oldHLS animals, however, resveratrol administration significantly reduced caspase 9
activity in gastrocnemius muscles from old non-HLS animals (p ≤ 0.05), eliminating the
aging effect (Figure 4C). HLS significantly (p ≤ 0.05) increased caspase 3 activity, in
gastrocnemius muscles from vehicle control-HLS animals; this increase was
significantly (p ≤ 0.05) attenuated by resveratrol administration.

DNA fragmentation. A cell death ELISA was used as an indicator of DNA
fragmentation and the data are presented as an apoptotic index. The apoptotic index
was increased by aging and HLS in rat gastrocnemius muscles, but resveratrol failed to
attenuate this increase. Old animals exhibited a 200% increase (p ≤ 0.05) in DNA
fragmentation regardless of resveratrol administration (Figure 4E). Similarly,
gastrocnemius muscles from both young and old HLS animals treated with, or without,
resveratrol, has significantly increased levels of fragmented DNA indicating greater
levels of apoptosis. HLS increased the apoptotic index by ~5 fold (p ≤ 0.05) in young
animals and ~3 fold (p ≤ 0.05) in old animals respectively. Resveratrol had no effect on
DNA fragmentation in any treatment group (Figure 4E).
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Gastrocnemius Muscle Wet Weight. Resveratrol attenuated the HLS-induced atrophy
of old rats. Gastrocnemius muscles from young animals were significantly heavier than
their older counterparts (2.28 ± 0.15g vs.1.55 ± 0.06g; p ≤ 0.05) (Figure 5A). HLS
elicited significant atrophy in the gastrocnemius muscles from young and old rats.
Gastrocnemius muscles from young HLS animals weighed on average 28.3% (p ≤ 0.05)
less than gastrocnemius muscles from young ambulatory control animals. Similarly,
gastrocnemius muscles from old-HLS animals weighed 26.1% (p ≤ 0.05) less than
gastrocnemius from old non-HLS animals. Resveratrol administration had no effect on
the muscle wet weight of gastrocnemius muscles from young animals following HLS
(1.62 ± 0.12g vs.1.65 ± 0.11g) (Figure 5A). Gastrocnemius muscle wet weight from old
vehicle control suspended animals (1.09 ±.09g) was 14.2% less than muscle wet weight
in old resveratrol-treated suspended animals (1.28 ± 0.07g). Although, this difference
did not quite reach statistical significance (p = 0.062), it reflects a potential for
resveratrol to protect against muscle loss in old animals. There were losses of both
body weight and muscle weight with HLS in old animals. To determine if resveratrol
provided a muscle specific but not a body weight specific effect, muscle weight was
normalized to the animal’s body weight. When muscle wet weight was normalized to
body weight, resveratrol administration significantly attenuated the relative proportion of
gastrocnemius muscle lost during HLS in old animals (2.21 ± 0.11mg/g vs. 2.80 ±
0.21mg/g; p ≤ 0.05) (Figure 5B). This preservation of relative muscle mass, but not body
weight following HLS was not seen in young animals that were administered resveratrol.

Refer to Figure 5
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Muscle Functional Measurements. The HLS-induced force loss was markedly
attenuated by resveratrol in old animals. Three in vivo maximal isometric contractions
were averaged to obtain the pre-HLS force record. This was repeated after HLS to
obtain the post–HLS force data. The percent decrease of in vivo isometric force was
determined by comparing the pre-HLS to post-HLS force records. Maximal isometric
measurements were obtained on age-matched ambulatory rats at the two time points
that corresponded to the pre-HLS and post-HLS measures in the experimental animals.
Maximal plantar flexor force did not change over the duration of the study period for
either young adult or old ambulatory rats (data not shown). Young animals lost an
average of 33.7% of their maximal isometric force following HLS, and resveratrol
administration did not attenuate the force loss in these animals (32.09 ± 9.79% vs.
35.37 ± 7.74%)(Figure 5C). However, resveratrol administration significantly preserved
isometric force output following HLS in old animals, (45.9 ± 6.8% vs. 31.6 ± 7.4%; p ≤
0.05) (Figure 5C). To determine if muscle force was preferentially maintained during
weight loss, we normalized isometric force to the animal’s body weight (Figure 5D).
When the percent decrease in isometric force following HLS was normalized to body
weight, old vehicle control-HLS animals lost a significantly larger (p ≤ 0.05) proportion
of isometric force output than did their young counterparts, (Figure 5D). This aging
effect was abolished with resveratrol administration.
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DISCUSSION

Oxidative stress is positively correlated with skeletal muscle atrophy induced by
aging (27), denervation (45), disuse (22) and immobilization (45). These atrophic stimuli
are associated with concomitant increases in lipid peroxidation (47), glutathione
oxidation (47), protein carbonyl formation (44) and myonuclear apoptosis (12).
Furthermore, oxidative stress is linked to proteolytic processes that mediate muscle loss
through caspase 3 activation (45). Although skeletal muscle disuse induces oxidative
stress in both young and old animals (6,28), skeletal muscle from older animals
possesses a higher basal level of oxidative stress placing more strain on the
endogenous antioxidant system, and thus leaving skeletal muscle from these animals at
greater risk for oxidative damage during periods of disuse, and subsequent diminished
recovery following disuse.
The current investigation sought to shed light on the mechanisms underlying
muscle atrophy with disuse and to ascertain if oxidative stress and/or apoptosis were
possible contributing factors. Furthermore, the present study sought to elucidate the
potential role of resveratrol administration to alleviate oxidative stress and apoptosis in
skeletal muscle from old and young animals. Dietary supplementation with the
polyphenol, resveratrol, has the potential to exert beneficial effects not only through its’
ability to directly scavenge free radicals (36,39) and upregulate components of the
endogenous antioxidant system (34), but also by its’ capacity to modulate the signal
transduction and gene expression of several pathways regulating cellular proliferation
(20,53), mitochondrial biogenesis (50,53), metabolism (41), and apoptosis (20). The
efficacy of acute resveratrol administration has been established for several
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pathological conditions (35,36,39); however, this study provides the first insight into the
use of resveratrol supplementation as a counter-measure to combat muscle loss and
function caused by disuse.
Hindlimb suspension resulted in a significant loss of gastrocnemius muscle mass
as estimated from muscle wet weight (Figure 5A). Although there was no significant
preservation of gastrocnemius muscle mass resulting from resveratrol administration,
there was a significant preservation of the relative ratio of muscle mass preserved
normalized to animal body weight in old HLS animals (Figure 5B). This protective effect
may suggest a preferential preservation of skeletal muscle tissue with resveratrol
administration in old animals following a prolonged period of disuse, since there was no
difference in the total percentage of body mass lost between old resveratrol
supplemented and old non-supplemented animals during the experimental period
(Table1). Likewise, in old, but not young animals, there was a partial maintenance of
maximal isometric force of the plantar flexor muscle group following HLS. The percent
decrease in isometric force following HLS in old resveratrol administered animals was
similar to the force decrements seen in the plantar flexors of young animals following
HLS, thus eliminating the interaction of age and suspension. The findings showing a
protective effect of resveratrol on force production in the current study, are consistent
with data from Lagouge and colleagues (23), showing greater muscle strength in mice
fed a high fat diet supplemented with resveratrol.
In general, the in vivo isometric force output that was measured in the current
study, is the sum of forces that were generated by all of the individual muscles
comprising the plantar flexor group. The plantar flexor muscle group consists of the
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soleus, plantaris and gastrocnemius muscles which, contribute approximately 6%, 16%
and 78% respectively, to the mass of the rat plantar flexor muscles (11,51). As a result,
the gastrocnemius muscle provides the greatest contribution to plantar flexion force
output, and thus, the partial preservation of relative gastrocnemius muscle wet weight
and plantar flexion force production are likely linearly related.
Resveratrol administration mediated endogenous antioxidant enzymes and
oxidative stress indices in old animals. Specifically, resveratrol administration
significantly increased MnSOD activity and protein content, but not CuZnSOD activity in
old HLS animals (Figure 2). This is analogous with data showing that resveratrol
protected against oxidative stress through the specific induction of MnSOD (39).
Additionally, in the current study, resveratrol administration increased the content and
activity of catalase in old non-suspended animals, but it did not further increase catalase
activity, or expression following HLS. This may be in part because catalase activity is
already increased with aging and HLS, so it may have reached a maximal point of
induction. Perhaps most importantly, resveratrol administration reduced indices of
oxidative stress in gastrocnemius muscles of old HLS animals, as estimated by H2O2
levels and the lipid peroxidation byproducts (MDA and HAE). This is congruent with
recent data from our laboratory and others that have shown that resveratrol protects
against H2O2 mitigated lipid peroxidation in vivo (39,41) and in vitro (4). The induction
of catalase by resveratrol has previously been demonstrated (39), and along with
increases in MnSOD, may represent important mechanisms by which resveratrol acts to
reduce H2O2 and H2O2-mediated damage. However, these protective effects of
increases in antioxidant enzyme activity and concomitant decreases in markers of
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oxidant load were not seen in young animals administered resveratrol, suggesting that
there is a differential effect of resveratrol in young and old animals. The fact that
resveratrol only seems to have an effect in old animals is interesting and is plausibly
due to different underlying signaling mechanisms that may occur in old animals during
disuse. It is also possible that younger animals are able to handle the stress of hindlimb
suspension and the subsequent detrimental effects that are associated with skeletal
muscle disuse and therefore the pre-conditioning effect of resveratrol administration
helps to augment the stress response in old, but not young animals where it is not
needed. This is congruent with our finding that H2O2 concentrations were not increased
in young animals following suspension. Although, lipid peroxidation markers were
increased in muscles from young suspended animals, despite no increases in H2O2
concentrations, this might indicate a temporal role of oxidative stress in young animals
during muscle disuse.
Oxidative stress is upstream of apoptotic signaling in muscle cells in vitro (46)
and results in the initiation of the intrinsic mitochondrial apoptotic pathway. Due to its
multi-nucleated cellular structure, skeletal muscle is an exception to the linear
relationship between apoptosis and cell death. Instead, apoptosis in skeletal muscle
results in a loss of myonuclei and consequent fiber atrophy (3). Myonuclei undergo
apoptosis in many muscle wasting conditions including, but not limited to, advanced age
(31), disuse (42,44) and denervation (1,43). Likewise, these conditions are also
associated with increases in oxidative stress (1,27) presumably mediated through
mitochondrial dysfunction, given the importance that the mitochondria play in
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maintaining cellular integrity via ROS production and the regulation of the apoptotic
pathway (2,17,44).
Resveratrol administration altered apoptotic signaling (e.g., Bcl-2, caspase 9
activity) but it did not appear to blunt overall myonuclear apoptosis in muscles from old
animals. Resveratrol administration increased the protein content of the anti-apoptotic
protein Bcl-2 in old non-HLS animals suggesting a preconditioning effect by which
resveratrol could potentially improve the apoptotic environment of skeletal muscle
undergoing disuse. Our data are in agreement with a study by Brito and colleagues
(12), suggesting that resveratrol was able to protect against oxidant-induced apoptotic
signaling through the upregulation of Bcl-2, without any reductions of Bax protein
content. Downstream of the mitochondrial mediated apoptotic signaling cascade are the
proteolytic caspase enzymes. Resveratrol administration significantly decreased
caspase 9 activity in old non-HLS animals and significantly decreased caspase 3
activity in old HLS animals. In parallel with the other findings from the current study,
caspase activity was only attenuated in the gastrocnemius muscles from old animals,
with no effect being seen in muscles from the young animals.
Interestingly, the alleviation of oxidative stress and damage in old HLS animals
administered resveratrol did not translate into protection from apoptosis as estimated
from the quantity of DNA fragmentation present following HLS. This suggests that the
protective effect of resveratrol may be in part to its anti-inflammatory and/or antiproteolytic capacities rather than anti-apoptotic capabilities. This would be in agreement
with the fact that resveratrol was able to decrease caspase 3 following HLS in old
animals, despite having no efficacy in ameliorating apoptosis following HLS. Caspase 3
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is known to be redox sensitive and to play an initiating role in muscle proteolysis via the
ubiquitin-proteasome system (20). Although it is not known why a significant increase in
Bcl-2 protein content did not confer resistance to apoptosis following HLS, it could be
speculated that the relative contribution of apoptosis versus necrosis and other
mechanisms of disuse mediated atrophy are temporal in nature. Since data in our study
were only collected at one time point (14 days), it is possible that early protection
against apoptosis was not detected, but it still may have contributed to the preservation
of muscle mass and maintenance of isometric force seen in old animals administered
resveratrol.
It is also probable, (although not evaluated in this study), that the protective
effects of resveratrol observed in the current investigation stem from the ability of
resveratrol to activate the silent mating type information regulation 2 homolog (Sirt1), a
NAD+ dependent histone deacetylase (20). Sirt1 has been shown to play a role in a
variety of important physiological functions including the regulation of oxidative stress.
Congruent with our current observations regarding resveratrol administration, Sirt1
activation is reported to upregulate the transcription of both MnSOD (48) and catalase
(15,16) and reduce reactive oxygen species-induced apoptosis (15). This highlights the
potential of Sirt1 to act as a protective mechanism against oxidative stress. The wide
range of Sirt1’s cell signaling capacity underscores the potential ability of resveratrol to
mediate a variety of cell signaling pathways and therefore provides many potential
therapeutic targets that may be responsible for the attenuation of skeletal muscle
atrophy and force preservation observed during disuse in old animals. Gaining clearer
insight into the molecular signaling pathways involved in aging and disuse muscle

71

atrophy is paramount in developing nutritional and/or pharmacological interventions to
minimize protein loss and attenuate the functional decrements associated with atrophic
conditions.
In summary, the results of the current study show that resveratrol treatment
reduces the functional decrements and the oxidative stress levels in rat hindlimb
muscles in response to disuse. One potential mechanism for improved muscle function
in resveratrol treated animals is via a Sirt1 mediated improvement in the endogenous
antioxidant enzyme activity and the redox status of the aging muscle during disuse.
However, it is also possible that the protective effects of resveratrol are unrelated to
Sirt1 or blunting oxidative stress. For example, administration of resveratrol has been
shown to attenuate protein degradation in murine myotubes treated with proteolysisinducing factor, enhanced the proliferation of muscle precursor cells (34), and blunted
muscle weight loss, and protein degradation, in vivo, in a mouse model of cachexia
(52). Additional studies are needed to determine if resveratrol activation of Sirt1 has the
potential to be an effective therapeutic intervention, by reducing ROS, or if resveratrol
functions via another mechanism, to lower the extent of loss of muscle mass or function
in aged humans, in response to reduced activity or bed rest.

Acknowledgements
This study was supported by funding from the National Institutes of Health:National
Institute on Aging Grant R01AG021530.

72

Table Legends

Table 2.1

Animal Body Weight. Animals were weighed pre and post-hindlimb
suspension (HLS). Body weights (BW) are represented in grams (g) and
as percent changes (%Δ) in body weights during the 21 day the
experimental protocol. YVC = Young Vehicle Control, YVCS = Young
Vehicle Control Suspended, YRC = Young Resveratrol Control, YRS =
Young Resveratrol Suspended, OVC = Old Vehicle Control, OVCS = Old
Vehicle Control Suspended, ORC = Old Resveratrol Control, ORS = Old
Resveratrol Suspended. **Denotes significantly difference (p ≤ 0.05)
between non-suspended treatment matched control (Suspension effect). #
denotes significantly different than young treatment matched (Aging
effect).
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FIGURE LEGENDS

Figure 2.1

Experimental protocol. Resveratrol was administered via oral gavage at
a dose of 12.5 mg/kg/day for 21 days. One milliliter of 0.01%
carboxymethylcellulose was used as a vehicle control. Following 7 days
of resveratrol administration animals were randomly assigned to 14 days
of hindlimb suspension (HLS), or continued ambulation. Following the
experimental protocol, the gastrocnemius muscles were dissected and
assessed for muscle wet weight, oxidative stress, and apoptotic indices.
MWW, muscle wet weight.

Figure 2.2

Enzymatic activities and protein contents of CuZnSOD, MnSOD and
catalase in response to aging and HLS (A) CuZnSOD activity was
assessed using a spectrophotometric assay and is expressed as units of
enzymatic activity (U)/mL/mg protein. (B) CuZnSOD protein content was
determined via immunoblotting; a representative blot is shown. (C)
MnSOD activity was assessed using a spectrophotometric assay and is
expressed as units of enzymatic activity (U)/mL/mg protein. (D) MnSOD
protein content was determined via immunoblotting; a representative blot
is shown. (E) Catalase activity was assessed using a spectrophotometric
assay and is expressed as milliunits of enzymatic activity (mU)/mg protein.
(F) Catalase protein content was determined via immunoblotting; a
representative blot is shown. YC= Young Control, YS = Young
Suspended, OC = Old Control, OS = Old Suspended, YVC = Young
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Vehicle Control, YVCS = Young Vehicle Control Suspended, YRC =
Young Resveratrol Control, YRS = Young Resveratrol Suspended , OVC
= Old Vehicle Control, OVCS = Old Vehicle Control Suspended, ORC =
Old Resveratrol Control, ORS = Old Resveratrol Suspended.** p ≤ 0.05,
non-suspended treatment vs. matched control (Suspension effect). # p ≤
0.05, young treatment matched (Aging effect). * p ≤ 0.05, vehicle control
vs. age-matched and treatment matched group (Effect of resveratrol).

Figure 2.3

Resveratrol attenuated increases in hydrogen peroxide (H2O2)
concentration and lipid peroxidation associated with HLS in old
animals. (A) H2O2 concentrations were determined fluorometrically in
gastrocnemius muscle homogenate. Data are expressed as
µmols/H2O2/µg protein. Significance was set at (p ≤ 0.05) and all data are
represented as mean ± standard error. (B) MDA and HAE levels were
evaluated as a combined marker of lipid peroxidation and expressed in
µM[MDA/HAE]/mg protein. YC= Young Control, YS = Young Suspended,
OC = Old Control, OS = Old Suspended, YVC = Young Vehicle Control,
YVCS = Young Vehicle Control Suspended, YRC = Young Resveratrol
Control, YRS = Young Resveratrol Suspended, OVC = Old Vehicle
Control, OVCS = Old Vehicle Control Suspended, ORC = Old Resveratrol
Control, ORS = Old Resveratrol Suspended. ** p ≤ 0.05, non-suspended
control vs. suspended animals (Suspension effect). # p ≤ 0.05, old vs.
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young treatment matched (Aging effect). * p ≤ 0.05, vehicle control vs.
age-matched and treatment matched groups (Effect of resveratrol).

Figure 2.4

The effects of resveratrol administration and HLS on apoptotic
signaling in young and old animals. (A) Bax protein content was
determined via immunoblotting; a representative blot is shown (B) Bcl-2
protein content was determined via immunoblotting; a representative blot
is shown (C) Caspase 9 Activity was assessed using a fluorometric assay
(D) Caspase 3 Activity was assessed using a fluorometric assay (E) Cell
Death ELISA YC= Young Control, YS = Young Suspended, OC = Old
Control, OS = Old Suspended, YVC = Young Vehicle Control, YVCS =
Young Vehicle Control Suspended, YRC = Young Resveratrol Control,
YRS = Young Resveratrol Suspended, OVC = Old Vehicle Control, OVCS
= Old Vehicle Control Suspended, ORC = Old Resveratrol Control, ORS =
Old Resveratrol Suspended. **p ≤ 0.05, non-suspended control vs.
suspended animals (Suspension effect). # p ≤ 0.05, old vs. young
treatment matched (Aging effect). *p ≤ 0.05, vehicle control vs. agematched and treatment matched groups (Effect of resveratrol).

Figure 2.5

Gastrocnemius muscle wet weight and plantar flexor maximal
isometric force. The gastrocnemius muscles were dissected,
immediately blotted and weighed as a gross estimation of muscle size and
represented in grams (g, A), or as ratio to the animal’s body weight (mg/g,
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B). Pre and post-HLS force measurements were assessed. Three
isometric contractions were recorded per animal for both pre and post–
HLS assessments. The average of the three contractions at each time
point was used to determine the decrease in isometric force output
following HLS. The average force decrease with HLS (C) or the decrease
in force normalized to body weight (D) demonstrates that resveratrol
preserved loss of function in hindlimb muscles of the old rats. Significance
was set at (p ≤ 0.05) and all data are represented as mean ± standard
error. YC= Young Control, YS = Young Suspended, OC = Old Control, OS
= Old Suspended, YVC = Young Vehicle Control, YVCS = Young Vehicle
Control Suspended, YRC = Young Resveratrol Control, YRS = Young
Resveratrol Suspended, OVC = Old Vehicle Control, OVCS = Old Vehicle
Control Suspended, ORC = Old Resveratrol Control, ORS = Old
Resveratrol Suspended. **p ≤ 0.05, non-suspended control vs. suspended
animals (Suspension effect). # p ≤ 0.05, old vs. young treatment matched
(Aging effect). *p ≤ 0.05, vehicle control vs. age-matched and treatment
matched groups (Effect of resveratrol).
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Figures

Figure 2.1: Experimental Protocol.
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Figure 2.2: Enzymatic activities and protein contents of CuZnSOD, MnSOD and
catalase in response to aging and HLS.

89

Figure 2.3: Resveratrol attenuated increases in hydrogen peroxide (H2O2)
concentration and lipid peroxidation associated with HLS in old animals.
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Figure 2.4: The effects of resveratrol administration and HLS on apoptotic signaling in
young and old animals.
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Figure 2.5: Gastrocnemius muscle wet weight and plantar flexor maximal
isometric force.
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ABSTRACT

This study analyzed the capacity of resveratrol, a naturally occurring polyphenol, to
reduce aging-induced oxidative stress, and protect against sarcopenia. Middle-aged
(18mo) C57/Bl6 mice were randomly assigned to receive either a control diet or a diet
supplemented with 0.05% trans-resveratrol for 10 months. Young (6mo) and middleaged (18mo) mice were used as controls. Resveratrol supplementation did not reduce
the aging-associated loss of muscle mass or improve maximal isometric force
production, but it appeared to preserve fast-twitch fiber contractile function. Resveratrol
supplementation did not improve mitochondrial content, the subcellular localization of
cytochrome c protein content, or PGC1 protein content. Resveratrol increased MnSOD,
reduced H2O2, and lipid peroxidation levels in muscle samples, but it was unable to
significantly reduce protein carbonyl levels. The data suggest that resveratrol has a
protective effect against aging-induced oxidative stress in skeletal muscle, likely through
the upregulation of MnSOD activity, but sarcopenia was not attenuated by resveratrol.

Key Words: Muscle atrophy-Oxidative stress—Sarcopenia—Mitochondria
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Introduction
Advanced age leads to a loss of muscle mass and function, termed sarcopenia
(64). The causative factors of sarcopenia are multifactoral, and include a progressive
denervation of muscle fibers (21), an altered hormonal milieu (75), and a net loss of
contractile proteins, (37; 57). While no causal relationship has been established,
skeletal muscle atrophy is often associated with an increased production of reactive
oxygen species (ROS), (48; 49; 56), leading to an amplified oxidant-load. An increase
in oxidant exposure, in conjunction with the less effective endogenous anti-oxidant
systems often present in aged animals (54; 58) can lead to oxidative stress. Chronic
oxidative stress left unchecked over time leads to the oxidation, and thus damage, of
cellular macromolecules, including lipids (53), nucleic acids (29) and proteins (11; 20;
30). This progressive and cyclical oxidative assault on cellular macromolecules is
believed to be an important contributor to the aging process (25) and is thought to be
responsible for many of the pathologies associated with aging, including genomic
instability, mitochondrial dysfunction and chronic inflammation (25; 26), all of which are
associated with sarcopenia (13).
Supplementation with the naturally occurring phytoalexin, resveratrol (3,4',5trihydroxystilbene), has recently been shown to protect against oxidative stress in
rodent skeletal muscle (32; 67) and to act as a systemic anti-inflammatory agent in vivo
(24). Specifically, in skeletal muscle, resveratrol has been shown to upregulate
components of the endogenous antioxidant system (32; 67), reduced the oxidant load
within the muscle environment and consequently attenuate oxidative damage
associated with muscle loading (67), unloading (32) and aging (32; 67). Furthermore,
resveratrol administration was able to significantly mitigate muscle atrophy in a mouse
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model of cachexia (80). Resveratrols’ ability to directly scavenge free radicals resides in
its phenol ring and resveratrol has repeatedly been shown to be a potent scavenger of
reactive oxygen species (ROS) in numerous cell types exposed to oxidants (12; 36; 47;
62). However, its rapid first pass metabolism in mammals and thus relatively low
bioavailability (19; 23; 46), may limit its role as a direct ROS scavenger in vivo.
Consequently, in vivo, resveratrols’ various health benefits can more likely be attributed
to its ability to activate the NAD+ dependent deacetylase, silent mating type information
regulation homolog1, or sirtuin1 (Sirt1) (2; 40).
Sirt1 has been shown to play a role in a variety of important physiological
functions including inflammation (24), mitochondrial biogenesis (40) and the regulation
of oxidative stress and anti-oxidant enzymes (27; 39) in a wide array of cell types (38;
40; 51; 78). Sirt1 is also activated with exercise (74) and under conditions of nutrient
deprivation (14; 79), underscoring resveratrols effectiveness as a caloric restriction
mimetic. These conditions in which Sirt1 activation is elicited are significant because
both exercise (71; 73) and caloric restriction (7; 14; 41) are proven countermeasures to
combat both oxidative stress and sarcopenia. Furthermore, Sirt1 is a powerful positive
mediator of PPARγ co-activator (PGC-1α) (76), which is considered to be the master
regulator of mitochondrial function and biogenesis (43). PGC-1α is decreased during
atrophic conditions (68; 69) and muscle specific over expression of PGC-1α confers
protection against both denervation and fasting-induced skeletal muscle atrophy (69).
Increases in PGC1 signaling have the potential to alleviate age-related mitochondrial
alterations which underlie a wide variety of diseases such as diabetes (45),
neurodegeneration (70) and sarcopenia (13).

96

Although mitochondria are not the sole source of ROS within a cell, they are
routinely viewed as the principle site of superoxide generation, which is the primary
source of damaging ROS within muscle cells (33; 34). Resveratrol’s ability to increase
PGC1 signaling, via Sirt1 activation, could potentially provide a two-fold mechanism with
which to protect aged skeletal muscle against oxidative stress. Firstly, resveratrol has
been shown to act as a direct and indirect anti-oxidant diminishing the likelihood of
phospholipid oxidation and thus damage within the mitochondrial membrane preserving
the integrity of the membranes and thus preventing “leaky” mitochondria. In addition,
resveratrol has been shown to promote mitochondrial biogenesis in skeletal muscle in a
Sirt1 dependent fashion (40) thus potentiating the possibility to replace damaged
mitochondria in aged animals.
Acute resveratrol administration has been recently shown to reduce oxidative
stress and improve functional outcomes in rodent skeletal muscle (32; 67); however, the
efficacy of chronic resveratrol supplementation as a counter-measure to combat
sarcopenia has not been established. Thus, the purpose of the current investigation was
to determine if long-term dietary supplementation, from middle-age through
senescence, with moderate doses of resveratrol would effectively attenuate the loss of
muscle mass and function that occurs in aged animals. It was hypothesized that
resveratrol’s ability to activate Sirt1 would consequently enhance the endogenous antioxidant system and increase PGC1 signaling, thereby reducing the release of ROS from
mitochondrion. Furthermore, it was hypothesized that resveratrol supplementation
would maintain muscle function in aged animals both by preservation of muscle mass
and by providing a more favorable redox environment
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Methods

Experimental Protocol. Experiments were conducted on young adult (3 mo), middleaged (18 mo) and aged (28 mo) C57BL/6 mice obtained from the National Institute on
Aging colony (Harlan, Indianapolis, IN). The mice were housed in pathogen-free
conditions at ~20oC. All mice had free access to food and water. Middle-aged mice were
put on either a control diet of normal mouse chow, (AIN-76A Rodent Diet, Research
Diets Inc, New Brunswick, NJ), or an identical diet containing 0.05% resveratrol
(Research Diets Inc, New Brunswick, NJ). Resveratrol was purchased from Orchid
Pharmaceuticals (India). Mice of 3 mo and 18 mo of age were used as control animals
only. Aged animals were sacrificed at 28 months after 10 months of being on either the
control, or resveratrol-supplemented diet. Immediately following sacrifice, skeletal
muscles were dissected for use in either biochemical analyses, mitochondrial isolation
and/or physiological analyses. All experimental procedures carried approval from the
Institutional Animal Use and Care Committee from West Virginia University School of
Medicine.

Ex vitro muscle physiological analysis. Isometric muscle contractile properties were
examined in the plantaris muscles of control and resveratrol-treated mice. The muscles
were placed in an oxygenated ringers solution (in mM: 137 mM NaCl, 4.7mM KCl,
3.4mM CaCl2, 1.2mM MgSO4 1 NaH2PO4, and 112 D-glucose). The Ringer solution
was aerated with 95% O2 and 5% CO, (pH 7.4). The temperature of the solution was
kept at 20°C. The distal end of the muscle was attached to a stationary plexiglass plate,
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and the proximal end was fixed to the lever arm of a 300C dynamometer (Aurora
Scientific, Aurora Ontario, Canada). The muscles were stimulated by passing a constant
current through platinum plates that were positioned on either side of the muscle. Ex
vivo isometric twitch and tetanic contractions were obtained using a Constant
Current/Constant Voltage Stimulator (Aurora Scientific) that provided DC-square wave
signals at stimulation current of 12 Volts, with a 200 µs pulse width. Muscles were
adjusted to the optimal muscle length (Lo) by a micromanipulator that controlled the
base position of the electrode clamp. Lo was established as the muscle length that
produced maximal isometric twitch tension. Lo was periodically checked by the same
procedure throughout each experiment. Force-frequency isometric force records were
obtained by stimulating the muscle at 10, 20, 40, 50, 75 and 100 Hz, with 3 minutes of
rest between each contraction. Physiological contractile measures included peak
isometric twitch force (PT), time to peak twitch contraction tension (CT), ½ relaxation
time of twitch contraction (½ RT), and peak isometric tetanic force (Po), as previously
described (3; 4). Following isometric contractions, the muscles remained in
oxygenated Ringers for 5 minutes prior to the repeated stimulation fatigue protocol.
Muscle fatigue was assessed by stimulating the muscle at 40Hz for 3 minutes with a
duty cycle of 330 ms of stimulation followed by 660 ms of rest (15). The fatigue index
was calculated as the difference in force from the average of the first three contractions
to the average of the final three contractions. The contractile and fatigue measurements
were analyzed off line using commercial software (DMI, Aurora Scientific).

Protein Isolation. Approximately 40 µg of gastrocnemius muscle from each animal
was homogenized in 500 μL of RIPA buffer (1% Triton x-100, 150mM NaCl, 5mMEDTA,
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10mM Tris; pH: 7.4) using a mechanical homogenizer, for use in the assessment of
protein expression via immunoblotting. Muscle homogenates were then centrifuged at
1000 x g for 5 minutes at 4°C. The resulting supernatant was collected and divided into
two portions and frozen at –80°C either with, or without a protease inhibitor cocktail
containing 104 mM 4-[2-aminoethyl]-benzenesulfonyl fluoride hydrochloride, 0.8 mM
aprotinin, 2 mM leupeptin, 4 mM bestatin, 1.5 mM pepstatin A, and 1.4 mM E-64
(Sigma-Aldrich, St. Louis, MO) added to it.

For all enzyme activity assays, and/or oxidative damage assessments muscle
samples were homogenized in the appropriate volume of either PBS, or the kit specific
buffer provide by the manufacturer. Protein concentrations for each sample were
determined in duplicate using the DC Protein Assay kit (Bio-Rad, Hercules, CA).

Mitochondrial isolation. The vastus lateralis muscles were carefully removed while the
mice remained under deep anesthesia (5% isoflurane / 95% oxygen). Precautions were
made to assure that the blood supply to the muscles remained intact until it was
removed to prevent the artificial accumulation of oxidants. Mitochondria and
mitochondria free cytosolic muscle fractions were obtained using a commercially
available mitochondrial isolation kit specifically designed for animal tissue (MITOISO11KT, Sigma-Aldrich Co., St Louis, MO). The fractions were obtained using sequential
separation steps involving a protease digestion followed by separation of the fractions
via centrifugation using slight modifications of the manufacturer’s recommendations.
Briefly, the gastrocnemius muscle was placed on ice and minced in a 1.5ml eppendorf
tube. Samples were washed and re-suspended in an extraction buffer containing 0.25
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mg/ml trypsin. After a 20 minute incubation period, albumin was added to a final
concentration of 10 mg/ml to quench the proteolytic reaction. Samples were then
washed and re-suspended in extraction buffer and then gently homogenized with a
Teflon pestle. The homogenate was then centrifuged at 600 x g for 5 minutes. The
supernatant was transferred to a new tube and centrifuged at 11,000 x g for 10 minutes
and transferred to a new tube. The supernatant was centrifuged for 10min at 11,000 x g
and transferred to a new tube to assure a clean mitochondrial free cytosolic fraction.
The mitochondrial pellet was suspended in a sucrose storage buffer.

Manganese Superoxide Dismutase (MnSOD) and Copper-Zinc Superoxide
Dismutase (CuZnSOD) Enzyme Activity Levels. Superoxide dismutase activity was
measured in vastus lateralis muscle homogenate that was partitioned into a
mitochondrial pellet and mitochondrial-free cytosolic fraction. Enzymatic activity was
assessed using a colorimetric enzyme activity kit (Cayman Chemical Company Ann
Arbor, MI) following the manufacturer’s guidelines. CuZnSOD activity was obtained from
the cytosolic fractions and MnSOD activity was measured using isolated mitochondria.
All samples and standards were measured in duplicate. The assay was performed in a
96-well plate and mitochondrial samples were treated with 10µL of 12 mM potassium
cyanide to inhibit any residual CuZnSOD activity. The absorbance of the resulting
colorimetric changes were measured at a wavelength of 450 nm using a 96-well plate
reader (Dynex Tech., Chantilly VA., USA). The samples were normalized to the protein
concentration in each sample as assessed using a DC protein concentration assay (BioRad, Hercules, CA).
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Immunoblots. The protein content of CuZnSOD and MnSOD were measured in vastus
lateralis total muscle homogenate. Cytochrome C protein content was measured in the
cytosolic (mitochondrial free) fraction of the vastus lateralis muscle, the corresponding
mitochondrial fractions and total muscle homogenate. The protein content of Sirt1 and
PGC-1 were measured in gastrocnemius total muscle homogenates. β-tubulin was used
as a loading control for cytosolic fractions and total homogenate. A ponceau stain was
used to validate equal loading of the mitochondrial fraction. Thirty to forty micrograms of
protein were loaded into each well of a 4%–12% gradient polyacrylamide gel (Invitrogen,
Carlsbad, CA) and separated by routine sodium dodecyl sulfate–polyacrylamide gel
electrophoresis (SDS–PAGE) for approximately 1.5hrs at 20°C, followed by transfer to a
nitrocellulose membrane for 70-120 min at 35V. All membranes were blocked in 5%
nonfat milk (NFM) for 1 hour at room temperature. Membranes were then incubated in
the appropriate primary antibodies, overnight at 4°C. Primary antibodies were diluted in
Tris-buffered saline, with 0.1% Tween-20 (TBST) and 10% sodium azide. Membranes
were then washed in 0.05% TBST followed by incubation in the appropriate dilutions of
secondary antibodies (diluted in 5% NFM in TBST) conjugated to horseradish
peroxidase. Signals were developed using a chemiluminescent substrate (Lumigen
TMA-6; Lumigen, Southfield, MI) and visualized by exposing the membranes to X-ray
films (BioMax MS-1; Eastman Kodak). Digital records were captured by a Kodak 290
camera, and protein bands were quantified using 1D analysis software (Eastman
Kodak). Bands were quantified as optical density x band area and expressed in arbitrary
units.
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Sirt1 Activity. Sirt1 activity was measured using components of the Sirt1 Fluorimetric
Drug Discovery Kit (BIOMOL, Plymouth Meeting, PA # AK -555). In short, endogenous
Sirt1 activity was measured in total gastrocnemius muscle homogenates homogenized
in ice-cold PBS (pH =8.0) using the fluorescent deacetylase substrate and developer
provided in the kit. Following homogenization each sample was quantified using a DC
protein concentration assay (Bio-Rad, Hercules, CA) and diluted to 2.5 µg/µL using the
kit supplied assay buffer. The fluorescent substrate in conjunction with 100 µM of the
co-substrate NAD+ was incubated with 25 µL of each sample for 30 minutes at RT in a
½ volume 96 well white microplate. Following this incubation 2mM Nicotinamide (Sirt1
inhibitor) and the provided fluorescent developer were added to each well to stop the
reaction and produce a fluorophore that is linearly related to Sirt1 activity. Resveratrol
and Suramin were combined with the provided recombinant Sirt1 and were used as
positive and negative controls respectively. Additionally, a mouse liver homogenate was
used as an additional positive control. The intensity of the fluorescent signal was
detected using an excitation wavelength of 360 nm and an emission wavelength of 460
nm. Data are presented as fluorescent units normalized to the milligrams of protein
present in each homogenate.

Citrate Synthase Activity. Citrate synthase activity was measured in gastrocnemius
whole tissue extracts using a commercially available kit (CS0720 Sigma-Aldrich, Saint
Louis, MO). Citrate synthase activity has been extensively used as a marker of
mitochondrial mass (40; 59) and is a suitable marker for use in whole muscle
homogenate given that it’s located in the mitochondrial matrix; the enzyme’s activity
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would be minimally affected by the homogenization procedure. Muscle samples were
homogenized in ice-cold CelLytic MT Cell Lysis Reagent (C3228) and the resultant
homogenate was centrifuged at 12,000 x g for 10 minutes to remove cellular debris. The
resulting supernatant was used for the kinetic assessment of citrate synthase activity.
The assay was performed in a 96 well plate as per manufactures instructions. Briefly,
8µL of each muscle homogenate was added to a master mix containing the supplied
assay buffer, 30mM Acetyl CoA solution and 10mM DTNB solution. The reaction was
initiated with the addition of 10µL of oxaloacetic acid and the formation of citric acid was
determined spectrophotometrically at a wavelength of 412nm at an interval of
90seoncds for 10minutes. Net citrate synthase activity was calculated as the
endogenous citrate synthase activity subtracted from total activity. All analyses were
measured in duplicate and the samples were normalized to µg of protein per μL of
muscle homogenate as determined by the DC Protein Assay Kit (Bio-Rad Hercules,
CA).

Hydrogen Peroxide (H2O2) Content. H2O2 content in gastrocnemius muscle
homogenate was measured using a fluorescent assay according to the manufacturer’s
recommendations (Cell Technology, Mountain View, CA). Briefly, 50 μL of control,
unknown muscle samples, or H2O2 standards were mixed with 50 μL of the reaction
cocktail provided in the kit and added to each well to initiate the reaction. The plate was
then incubated in the dark for 10 minutes at room temperature. The intensity of the
fluorescent signal was detected using an excitation wavelength of 530 nm and an
emission wavelength of 590 nm. A linear regression was performed by plotting the
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resultant florescent intensities from the known standards and subsequently the
unknown samples were fit to the corresponding linear equation. All analyses were
measured in duplicate and the samples were normalized to µg of protein per μL of
muscle homogenate as determined by the DC Protein Assay Kit (Bio-Rad Hercules,
CA).

Lipid Peroxidation. Malondialdehyde (MDA) and 4-hydroxyalkenals (HAE) were
measured using the methods and reagents from Oxis International, CA (BIOXYTECH
LPO-586). Approximately 50 mg of gastrocnemius muscle was homogenized in 750 μL
of ice cold buffer containing phosphate-buffered saline (20 mM, pH 7.4) and 5 μL of 0.5
M butylated hydroxytoluene in acetonitrile per 1 mL of tissue homogenate. Assay
reagents were added following the manufacturer's recommendations and have been
previously described by our laboratory (66). Briefly, the muscle homogenate was
centrifuged at 3000 x g at 4°C for 10 minutes, and the supernatant was carefully
collected and used to quantify lipid peroxidation. The supernatant was subsequently
incubated in the proper reagents at 45°C for 60 minutes, as per the manufactures
instructions, and then centrifuged at 15,000 x g for 10 minutes. The absorbance of the
resulting sample was read at 586 nm. All analyses were measured in duplicate and the
samples were normalized to µg of protein per μL of total gastrocnemius muscle
homogenate as determined by the DC Protein Assay Kit (Bio-Rad Hercules, CA).

Protein Carbonyls. A colorimetric protein carbonyl assay kit (#10005020 Cayman
Chemical Company, Ann Arbor, MI) was used to determine the level of protein oxidation
in gastrocnemius muscle homogenates. All procedures were carried out according to
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the manufactures guidelines. In brief, ~50mg of gastrocnemius muscle was
homogenized in ice-cold PBS (pH = 6.7) containing 1mM EDTA and subsequently
centrifuged for 10,000 x g for 15min at 4°C to obtain a clear supernatant. 400 µL of the
supernatant was subsequently transferred to two separate tubes, one to be used as a
background control and one to be used to asses protein carbonyl formation. 2,4dinitrophenylhydrazine was added to the sample tube and 2.5 M hydrochloric acid was
added to each control tube. Both tubes were then incubated in the dark for 1 hour at
room temperature. Following this incubation 20 % trichloroacetic acid was added to all
tubes and then briefly placed on ice. The samples were then exposed to a series of
sequential acid incubations, centrifugations and wash steps as per the manufactures
directions. After the final wash the pellets were re-suspended in guanidine hydrochloride
and transferred to the wells of a 96 well plate. The absorbance change was then
measured at a wavelength of 360nm using a plate reader. Following the readings all
samples were quantified using a DC protein concentration assay (Bio-Rad, Hercules,
CA) and the results are presented as nmols of protein carbonyls normalized to the µg of
protein present in each sample.

Statistics. Statistical analyses were performed using the SPSS 13.0 software package
(SPSS, Chicago, IL). An analysis of variance was used to examine differences between
the three age groups and additionally resveratrol supplementation. Bonferroni post hoc
analyses were performed between significant means. A p value < 0.05 was considered
statistically significant. Data are reported as mean ± standard error of the mean.
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RESULTS

Descriptive Data. All animals were weighed at the beginning and end of the
experimental protocol. The data displayed in Table 1 are indicative of the final weight of
the animals immediately prior to sacrifice. There was no significant difference between
the body weights of aged control vs. aged resveratrol supplemented animals. Middleaged and both aged animal groups were significantly heavier than young animals (34.3
± 2.3g vs. 34.5 ± 3.9g vs. 26.5 ± 2.1g; p ≤ 0.05). There was no significant effect of
resveratrol administration on body weight within aged animals. Conversely, both
gastrocnemius and plantaris muscle wet weights were significantly greater in young
animals compared to aged and middle-aged animals. The difference was even more
prominent when muscle wet weights were normalized to their body weights, (Table 1).
These results are indicative of sarcopenia; however, resveratrol showed no protective
effect with regard to maintaining muscle mass during aging in either the plantaris, or
gastrocnemius muscles.

Refer to Table 1

Silent mating type information regulation homolog1, (Sirt1) Enzyme Activity and
Protein Content. Surprisingly, Sirt1 Activity was significantly greater by 25% in
gastrocnemius muscles from aged animals, compared to their young counterparts.
Gastrocnemius muscles from resveratrol supplemented animals had a modest, but
additional increase in Sirt1 activity (2867 ± 108 vs. 3243 ± 107 AFU/µg), (Figure 1A).
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Sirt1 protein content, as measured by immunoblotting, was similarly greater in muscles
from aged animals, although to a much larger extent than the activity levels. Muscles
from aged animals showed, more than a two-fold greater Sirt1 protein content
compared to muscles from young animals. Resveratrol supplementation did not
significantly increase Sirt1 protein content in muscles of middle-aged animals, although
the results approached statistical significance (p= .063), (Figure 1B).

Refer to Figure 1

Peroxisome proliferator-activated receptor gamma coactivator 1 (PGC1) Protein
Content and Citrate Synthase Enzyme Activity. PGC1 protein content and citrate
synthase activity were measured as indirect markers of oxidative metabolism and
mitochondrial content, respectively. PGC1 protein content measured in total
gastrocnemius muscle homogenate remained unchanged regardless of age, or
resveratrol supplementation, (Figure 2A). Citrate synthase activity was ~20% lower in
muscles from aged animals, but resveratrol supplementation had no effect on the
enzyme’s activity (Figure 2B).

Refer to Figure 2

Subcellular Localization of Cytochrome c Protein. Cytochrome c protein content
was measured, via immunoblotting, in the total, cytosolic (mitochondrial-free), and
mitochondrial fractions of vastus lateralis muscles as an estimation of both
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mitochondrial content and mitochondrial membrane permeability. Cytochrome c protein
content in both the total homogenate and the mitochondrial fractions, remained
unchanged regardless of age or resveratrol supplementation (Figure 3A). Cytochrome c
present in the mitochondrial free cytosolic fraction was ~ 10 fold greater in muscles from
both middle-aged and aged animals regardless of resveratrol supplementation,
suggesting increased mitochondrial membrane permeability and perhaps an increased
likelihood of mitochondrial dysfunction present in middle-aged and aged animals (Figure
3A).

Refer to Figure 3

SOD Enzyme Activity and Protein Content. Superoxide dismutase activity was
measured in vastus lateralis muscles fractioned into mitochondrial and cytosolic
(mitochondrial-free) fractions. MnSOD activity was assessed in isolated mitochondria
and CuZnSOD activity was measured in the corresponding mitochondrial free cytosolic
faction. Total homogenates from the vastus lateralis muscle was used to determine the
protein content of each SOD isoform. MnSOD activity was similar in mitochondria
isolated from vastus lateralis muscles from middle-aged and aged animals relative to
young muscles. Resveratrol supplementation increased MnSOD activity in muscles
from aged animals by an additional ~40%, (Figure 4A). There was no aging, or
supplementation effect on MnSOD protein content (Figure 4B). CuZnSOD activity was
significantly increased in gastrocnemius muscles from old animals compared to
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gastrocnemius muscles from young animals (121 ± 6.3 vs. 73.8 ± 6.6 U/ml/mg; p ≤
0.05). Resveratrol supplementation significantly decreased CuZnSOD activity in aged
animals, by 33%, reducing the enzymes activity level to that of young animals (Figure
4C). There was no change in CuZnSOD protein content with resveratrol
supplementation, however, aging significantly increased CuZnSOD protein content in
both middle-aged and aged animals compared to their young counterparts, (Figure 4D).

Refer to Figure 4

Hydrogen Peroxide (H2O2) Concentrations. H2O2 was assessed in gastrocnemius
muscle homogenates as an indicator of oxidant load during aging. H2O2 levels were
~80% higher in gastrocnemius muscles from aged and middle-aged animals when
compared to gastrocnemius muscles from young animals, (1.88 ± 0.11 vs. 1.80 ± 0.25
vs. 1.05 ± 0.12 μmols H2O2 /μg protein; p ≤ 0.05). Resveratrol supplementation
significantly reduced H2O2 levels in gastrocnemius muscles from aged animals
compared to gastrocnemius muscles from old control animals, (1.52 ± 0.10 vs. 1.88 ±
0.11 μmols H2O2 /μg protein; p ≤ 0.05). This reduction represented a 24% decrease in
H2O2 concentrations, but muscles from aged resveratrol animals still had significantly
higher levels of H2O2 when compared to young muscles (Figure 5A).

Lipid Peroxidation. Malondialdehyde (MDA) and 4-hydroxyalkenals (HAE) were
assessed in whole muscle homogenates as indicators of oxidative damage, specifically
as markers of muscle lipid peroxidation. Lipid peroxidation was increased in aged
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animals compare to their young counterparts (0.251 ± 0.04 vs. 0.442 ± 0.05 µM
[MDA/HAE]/mg protein; p ≤ 0.05). Muscles from middle-aged animals did not show
elevated markers of lipid peroxidation when compared to muscles from young animals.
Resveratrol supplementation was able to partially attenuate the increase in lipid
peroxidation that occurred due to aging. Gastrocnemius muscles from aged
supplemented animals had a 20% reduction in MDA and HAE levels compared to aged
control animals (0.354 ± 0.02 vs. 0.442 ± .05 µM [MDA/HAE]/mg protein; p ≤ 0.05),
(Figure 5B).

Protein Oxidation. Protein carbonyl formation was measured in gastrocnemius muscle
homogenates as an indicator of protein oxidation caused by oxidative stress. Muscles
from both aged and middle-aged animals showed significantly greater concentrations of
protein carbonyl formation compared to muscles from their young counter parts (7.43 ±
1.3 vs. 7.10 ± 1.2 vs. 4.63 ± .67 nmol/ml/µg; p ≤ 0.05). Resveratrol supplementation was
unable to mitigate protein oxidation in aged animals as measured by carbonyl formation
(Figure 5C).

Refer to Figure 5

Ex Vitro Physiological Analyses. Isometric muscle contractile properties were
examined in the plantaris muscles of control and resveratrol-treated mice (Figure 6).
The force frequency curve was shifted significantly rightward in resveratrol
supplemented aged mice, compared to aged control mice (Figure 6A). This rightward

111

shift is indicative of a faster muscle profile. These results were completely unexpected
given that previous literature has shown that dietary resveratrol supplementation
improves muscular endurance (40) and increases mitochondrial biogenesis in skeletal
muscle (6; 40) which would likely shift the force frequency curve leftward to represent a
slower muscle profile. Additionally, CT and ½ RT were analyzed to determine if
resveratrol had any effect on the twitch properties of plantaris muscles, (Figure 6B).
Plantaris muscles from middle-aged animals had a significantly shorter contraction
times than did muscles from aged control animals, (32.8 ± 2.1 ms vs. 39.6 ± 1.4 ms; p ≤
0.05). Similarly, muscles from resveratrol supplemented animals also showed shortened
contraction times compared to aged control animals (34.7 ± 0.8 ms vs. 39.6 ± 1.4 ms; p
≤ 0.05), eliminating any aging effect between middle-aged and aged resveratrol
supplemented animals. These data are consistent with the rightward shift in the force
frequency curve of muscles from resveratrol supplemented animals (Figure 6.A). No
differences were found in the ½ RT (Figure 6.B), or the twitch to tetanus ratio (Pt/Po) of
plantaris muscles with respect to age or resveratrol supplementation, (Figure 6C).
Lastly, a modified Burke protocol (10) was implemented to assess muscle fatigue in
plantaris muscles. The fatigue protocol consisted of 3 minutes of 120 electrically evoked
contractions at 40 Hz. Each contraction was for 1.0s with a 33.3% duty cycle. The pulse
duration was 200 µs. There was no difference between the fatigue index of middle-aged
and aged control animals and furthermore, resveratrol was unable to improve fatigue
resistance in plantaris muscles (Figure 6D).

Refer to Figure 6
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DISCUSSION
Oxidative stress is believed to be a common underlying mechanism potentiating
many of the factors leading to muscle loss with aging (22; 56). There appears to be
inherent alterations in the endogenous antioxidant defense systems that occur with
aging in skeletal muscle (54; 58). Although there is an incongruence in the literature as
to whether antioxidant enzyme activities increase, or decrease, with aging; there is an
abundance of evidence suggesting that the antioxidant defense system in aged
individuals can be more easily overwhelmed by oxidants leading to oxidative stress and
consequent oxidative damage (53; 65; 72). Increased oxidant production and/or an
attenuated capacity to buffer oxidants may result in reductions in muscle function due to
both muscle atrophy and also functional decrements that go beyond the linear
relationship between muscle cross-sectional area and force generation (16; 31; 61).
Given that the definition of sarcopenia is the loss of muscle mass and function with
aging, (64) it stands to reason that there may be a possible link between increases in
oxidative stress with aging and the progression of sarcopenia.
The source of increased ROS present in aged skeletal muscle most likely
originates in the mitochondria. Age-related mitochondrial alterations underlie a wide
variety of diseases such as diabetes (45), neurodegeneration (70) and sarcopenia (13).
The premise behind this relationship is based on the theory that with advanced age
there are more dysfunctional mitochondria present within a cell (44). These defective
mitochondria contain “leaky” electron transport chains and thus more oxidants are
produced leading to oxidative stress (13; 28). The process is cyclic; with more
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mitochondrial uncoupling, there are more pro-oxidants present to further damage
vulnerable membrane phospholipids (28; 53). Consequently mitochondrial derived
superoxide generation increases with advanced age (50).
Supplementation with the naturally occurring polyphenol, resveratrol, has the
potential to alleviate oxidative stress in aged skeletal muscle via activation of Sirt1, by
favorably augmenting endogenous anti-oxidant enzymes (27; 39) and enhancing
mitochondrial function (40) and biogenesis (6). The present study sought to determine
the efficacy of long-term resveratrol supplementation to alleviate oxidative stress from
middle-age through senescence and to attenuate the progression of sarcopenia.
As expected, sarcopenia was present in both plantaris and gastrocnemius
muscles from aged animals (Table1). Interestingly, although muscles from middle-aged
animals were also significantly heavier than muscles from aged animals, when
normalized to bodyweight, muscles from middle-aged animals already showed a relative
decrease in muscle mass when compared to muscles from young animals. Counter to
our hypothesis, resveratrol supplementation was not able to attenuate the loss of
muscle mass or relative muscle mass in aged animals, nor did dietary resveratrol
supplementation affect animal body weight (Table1).
Resveratrol supplementation moderately, but significantly, enhanced Sirt1 activity
(Figure 1A) in gastrocnemius muscles from aged animals compared to muscles from
animals on the control diet. There was a tendency for Sirt1 protein levels to be elevated
by dietary resveratrol supplementation, however, these results did not reach statistical
significance (p=0.063) (Figure 1B) and this is congruent with literature showing that
supplementation with resveratrol primarily acts via increasing Sirt1 activation, not
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protein content (6). Somewhat unexpectedly, both Sirt1 activity and protein levels
increased with aging (Figure 1A-B). We had originally theorized that Sirt1 activity would
be decreased in aged animals in light of the fact that upregulation of Sirt1, with
resveratrol, can protect against certain facets of aging (5; 55). However, Sirt1 has
recently been found to be upregulated in heart muscle in response to both exogenous
stress and aging (1), suggesting that Sirt1 is elevated in muscles of aged animal and
likely represents an attempt to confer protection against endogenous and exogenous
stressors. These results are in agreement the findings of the current study.
Nevertheless, this elevation in Sirt1 protein and activity was insufficient to protect
skeletal muscle against sarcopenia.
Sirt1 is a known positive regulator of PGC1 (63) and as such has the potential to
influence pathways involved in mitochondrial biogenesis and oxidative metabolism.
Long-term resveratrol supplementation did not increase total PGC1 protein content in
aged gastrocnemius muscles, nor did total PGC1 protein content change with aging
(Figure 2 A). Given that total PGC1 protein levels may not be sensitive to changes in
the actual functional capacity of PGC1, the enzymatic activity of citrate synthase was
also analyzed as a marker of oxidative metabolism and mitochondrial content. Citrate
synthase activity was similarly unaffected by resveratrol supplementation, however,
citrate synthase activity was sensitive to age-related alterations and was significantly
decreased in aged animals, (Figure 2B). Congruent with the results of the citrate
synthase assay, cytochrome c release from the mitochondria was increased in muscles
from aged and middle-aged animals, but was not ameliorated with resveratrol
supplementation, (Figure 3A). It should be noted that in the current investigation the
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subcellular localization of cytochrome c was used as an indicator of mitochondrial
membrane integrity and content, although traditionally cytochrome c release is used as
a hallmark of apoptosis (1) . Taken as a whole, these data seem to indicate that
although Sirt1 activity was enhanced with resveratrol supplementation, it was not
increased enough to enhance PGC1 signaling and thus had no measurable influence
on mitochondrial membrane integrity, mass, or metabolism.
Long-term resveratrol supplementation was successful at mediating endogenous
antioxidant enzymes and markers of oxidative stress and oxidative damage in muscles
from aged animals. Specifically, resveratrol administration significantly increased
MnSOD activity, while having an opposing effect on CuZnSOD activity by significantly
decreasing it in vastus lateralis muscles, (Figure 4A & C). On the other hand, resveratrol
supplementation did not alter either SOD isoform at the protein level (Figure 4 B & D).
The ability of resveratrol to induce MnSOD is commonly accepted and it is believed that
resveratrol augments Sirt1 activity which in turn upregulates MnSOD in a FOXO3a
dependent manner (77). Acute resveratrol supplementation has previously been shown
to enhance MnSOD at both a gene (67) and protein (32) level in addition to enhancing
the enzyme’s activity, suggesting that there may be differential signaling with regard to
MnSOD regulation between acute and chronic exposure to resveratrol. CuZnSOD
activity is known to be increased with aging and in other conditions eliciting elevated
levels of oxidative stress (35), so it seems plausible that resveratrol’s ability to reduce
the muscle’s oxidant load by reducing of H2O2 concentrations (Figure 5 A) may have
prevented the aging-induced increase in CuZnSOD activity, resulting in a younger
antioxidant profile.
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The reduction of H2O2 concentrations in gastrocnemius muscles from aged
animals supplemented with resveratrol appears to have assuaged the accumulation of
the lipid peroxidation byproducts Malondialdehyde (MDA) and 4-hydroxyalkenals (HAE).
This is consistent with recent data from our laboratory and others that have shown that
resveratrol protects against H2O2 mitigated lipid peroxidation in vivo (32; 67) and in vitro
(9). Although the muscle oxidant load (H2O2) was reduced and the level of lipid
peroxidation was attenuated in aged gastrocnemius muscles, resveratrol
supplementation was unable to protect skeletal muscle from aging-induced protein
oxidation as measured by protein carbonyl formation (Figure 5C). This observation
differs from recent rodent studies in both diabetic (52) and cancer (8) models showing
that resveratrol was able to diminish protein oxidation in vivo. It is probable that the
results of the current study are more representative of the effects that resveratrol can
have under basal conditions in aged animals and it may prove to be more protective
under perturbations that involve excessive stress such as disease states and/or injuries
resulting in chronic inflammation, or under muscle wasting conditions such as cachexia
or hindlimb suspension.
Given that resveratrol supplementation has been shown to improve muscular
endurance (40) and increase mitochondrial biogenesis in skeletal muscle (6; 40), it was
conjectured that the primarily fast twitch plantaris muscles from supplemented animals
would show an improved resistance to fatigue. Presumably these muscles would show
a shift in muscle characteristics that would be more in line with a slower muscle
phenotype. This did not turn out to be the case, and in fact, resveratrol supplementation
not only conferred no protection against muscle fatigue (Figure 6D), it in fact shifted the
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force-frequency curves of the plantaris muscles rightward (Figure 6A), indicating that
the muscles had properties more consistent with a faster phenotype. One possible
explanation for this phenomenon is that resveratrol supplementation, by retarding
oxidative stress and damage, may have prevented the atrophy and/or loss of type II
fibers that is known to occur in aged skeletal muscle (42) and thus was able to preserve
a younger muscle profile. It is also possible, although not addressed in the current
study, that resveratrol could improve the capacity of aged muscles to regenerate. In a
recent study, resveratrol stimulated muscle precursor cell proliferation in a Sirt1dependent manner (60), further expanding the mechanisms by which resveratrol
supplementation may improve muscle mass and function by enhancing muscles
regenerative capacity, which has been shown to be augmented with aging (17; 18) and
in certain pathological conditions.
Taken as a whole, the results of the current study indicate that long-term dietary
supplementation with moderate doses of resveratrol may prove to be beneficial by
upregulating MnSOD and thus reducing the oxidant load present in the skeletal muscle
environment and hence preventing some measures of oxidative damage. However, the
current experimental protocol proved to be insufficient to enhance mitochondrial
integrity or content. It is possible that a greater increase in Sirt1 protein and/or activity
may be needed before a change in mitochondrial function will be observed. Further
work is needed to determine if resveratrol has the potential to be an effective
therapeutic agent to treat muscle functional decrements associated with elevated
oxidative stress in aged individuals or in conditions of muscle loss such as prolonged
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bedrest, presumably through a pharmacological pre-conditioning effect resulting in an
improved redox status associated with these conditions.
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TABLE LEGENDS

Table 1

Descriptive Data. Animals were weighed prior to sacrifice, body weights
(BW) are represented in grams (g). Gastrocnemius and plantaris muscles
were dissected, immediately blotted and weighed as an estimate of
muscle size. The data are presented in grams (g), or as a ratio to the
animal’s body weight (mg/g). Food consumption was assessed for each
experimental group and is reported as g of food per day. Resveratrol was
fed to aged mice for 10 months in a rodent chow that contained 0.05%
trans-resveratrol. Resveratrol intake is reported as grams per day
normalized to kg of bodyweight (g/kg/day). Significance was set at (p ≤
0.05) and all data are represented as mean ± standard error.
significantly different than young animals (Aging Effect).
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#

denotes

FIGURE LEGENDS

Figure 1

Silent mating type information regulation homolog1 (Sirt1) enzyme
activity and protein content. (A) Sirt1 protein content was measured via
immunoblotting in total gastrocnemius muscle homogenate (B) Sirt1
enzyme activity was determined fluorometrically in gastrocnemius muscle
homogenate. Data are expressed as arbitrary fluorescent units (AFU)/µg
protein. YC= Young Control, MAC = Middle-Aged Control, AC = Aged
Control, AR = Aged Resveratrol. Significance was set at (p ≤ 0.05) and
all data are presented as mean ± standard error. # p ≤ 0.05, young control
(Aging Effect). * p ≤ 0.05, aged control vs. age resveratrol
(Supplementation Effect).

Figure 2

PGC1 protein content and citrate synthase enzyme activity (A) PGC1
protein content was measured via immunoblotting in gastrocnemius
muscle homogenate (B) Citrate synthase enzyme activity was measured
kinetically in homogenates from gastrocnemius muscles. Data are
expressed as µmol/min/mg protein. YC= Young Control, MAC = MiddleAged Control, AC = Aged Control, AR = Aged Resveratrol.
Significance was set at (p ≤ 0.05) and all data are represented as mean ±
standard error. # p ≤ 0.05, young control (Aging Effect). * p ≤ 0.05, aged
control vs. age resveratrol (Supplementation Effect).
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Figure 3

Subcellular cytochrome c protein content. (A) Cytochrome c protein
content was measured, via immunoblotting, in the total, cytosolic
(mitochondrial-free), and mitochondrial fractions of vastus lateralis
muscles as an estimation of both mitochondrial content and mitochondrial
membrane integrity. (B) Immunoblots of the mitochondrial form of SOD
(MnSOD) and the cytosolic form of SOD (CuZnSOD) to illustrate the purity
of the tissue fractions. YC= Young Control, MAC = Middle-Aged
Control, AC = Aged Control, AR = Aged Resveratrol. Significance was
set at (p ≤ 0.05) and all data are represented as mean ± standard error.

#

p ≤ 0.05, young control (Aging Effect). * p ≤ 0.05, aged control vs. age
resveratrol (Supplementation Effect).

Figure 4

Isoform specific superoxide dismutase activity and protein content.
(A) MnSOD activity was assessed colorimetrically in mitochondria isolated
from vastus lateralis muscles. Data are expressed as U/mL/mg protein.
(B) MnSOD protein content was analyzed via immunoblotting in isolated
mitochondria of vastus lateralis muscles (C) CuZnSOD activity was
assessed colorimetrically in the mitochondria-free cytosolic fraction from
vastus lateralis muscles. Data are expressed as U/mL/mg protein. (D)
CuZnSOD protein content was analyzed via immunoblotting in the
mitochondria-free cytosolic fraction of vastus lateralis muscles. YC=
Young Control, MAC = Middle-Aged Control, AC = Aged Control, AR
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= Aged Resveratrol. Significance was set at (p ≤ 0.05) and all data are
represented as mean ± standard error. Significance was set at (p ≤ 0.05)
and all data are represented as mean ± standard error. # p ≤ 0.05, young
control (Aging Effect). * p ≤ 0.05, aged control vs. age resveratrol
(Supplementation Effect).

Figure 5

Resveratrol attenuated increases in hydrogen peroxide (H2O2)
concentration and lipid peroxidation associated with aging, but did
not prevent protein carbonyl formation. (A) H2O2 concentrations were
determined fluorometrically in gastrocnemius muscle homogenate. Data
are expressed as µmols/H2O2/µg protein. Significance was set at (p ≤
0.05) and all data are represented as mean ± standard error. (B) MDA &
HAE levels were evaluated as a combined marker of lipid peroxidation and
expressed in µM[MDA/HAE]/mg protein. (C) Protein carbonyl formation
was analyzed as a marker of protein oxidation in gastrocnemius muscle
homogenate. Data are expressed as nmol/mL. YC= Young Control,
MAC = Middle-Aged Control, AC = Aged Control, AR = Aged
Resveratrol. Significance was set at (p ≤ 0.05) and all data are
represented as mean ± standard error.

#

p ≤ 0.05, young control (Aging

Effect). * p ≤ 0.05, aged control vs. age resveratrol (Supplementation
Effect).
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Figure 6

In vitro muscle physiological analyses. Isometric muscle contractile
properties were examined in the plantaris muscles of control and
resveratrol-treated mice. (A) Graphical depiction of a force frequency
curve illustrating the maximal force produced in plantaris muscles at a
given frequency. Data are presented as the force production at a given
stimulation frequency relative to maximal force of that muscle. (B)
Contraction time (CT)and ½ relaxation time (½ RT) were analyzed to
determine twitch properties in plantaris muscles. Data are presented as a
unit of time (ms) (C) The twitch to tetanus ratio (Pt/Po) was assessed in
plantaris muscles. Data are presented as a ratio of twitch force to maximal
force.(D) A modified Burke protocol was implemented to asses muscle
fatigue in plantaris muscles. Data are presented as a measure of fatigue
index, calculated as a percent change from the first to last contraction
(120th). MAC = Middle-Aged Control, AC = Aged Control, AR = Aged
Resveratrol. Significance was set at (p ≤ 0.05) and all data are
represented as mean ± standard error. * p ≤ 0.05, aged control vs. age
resveratrol (Supplementation Effect).
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Chapter 4: General Discussion and Conclusions:

Overview:
The overall goal of this dissertation was to determine the efficacy of resveratrol
supplementation to ameliorate the detrimental relationship between oxidative stress,
apoptosis and skeletal muscle atrophy as they pertain to both muscle disuse and aging.
Furthermore, the included studies sought to elucidate resveratrol’s capacity to
upregulate silent mating type information regulation homolog1, (Sirt1), and to determine
if upregulation of Sirt1 by resveratrol would enhance mitochondrial integrity and content.
Our long-term goal was to determine if supplementation with resveratrol could prove to
be an effective therapeutic agent to attenuate muscle atrophy associated with chronic
disuse (hypodynemia and hypokinesia) and also to ascertain if long-term
supplementation with dietary resveratrol could prove to be an effective countermeasure
to slow the progression of sarcopenia, the age-associated loss of muscle mass and
function.
The central hypothesis of the dissertation was that resveratrol would protect
skeletal muscle from oxidative stress via upregulation of the endogenous antioxidant
system and augmentation of mitochondrial membrane integrity. This would result in a
reduction of both oxidant release and pro-apoptotic protein release from the
mitochondria, the leading to reduction in oxidative damage and downstream apoptosis,
with the expected outcome to be an attenuation of muscle atrophy. The rational for the
project was to shed light on molecular mechanisms of muscle atrophy induced by both
aging and disuse and to attempt to a possible intervention, via resveratrol
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supplementation, to help limit increased oxidant exposure and thus an atrophic muscle
environment.
Taken as a whole the cumulative results of the dissertation are in agreement with
the majority of the current literature confirming that increases in oxidative stress occur
concomitantly with both disuse-mediated skeletal muscle atrophy (chapter 2) and
sarcopenia (chapter 3). Furthermore, apoptotic signaling in the skeletal muscle
environment was increased in response to both hindlimb suspension and advanced age
(chapter 2). The novelty of this dissertation was to evaluate the efficacy of resveratrol
supplementation to attenuate oxidative stress and thus mitigate downstream mediators
of muscle atrophy.
The efficacy of resveratrol to mitigate the effects of skeletal muscle disuse:
Hindlimb suspension (HLS), which is a model that elicits both hypodynemia and
hypokinesia in conjunction with unloading of the hindlimb muscles, caused significant
atrophy of gastrocnemius muscles from both young and aged animals (Figure 2.5).
Oxidative stress and apoptotic signaling were also elevated in response to HLS in
muscles from both young and aged animals, although to a greater extent in muscles
from aged animals. This study yielded mixed results with regard to the efficacy of
resveratrol administration to ameliorate disuse mediated atrophy. With the exception of
the upregulation of catalase activity (Figure 2.4) in muscles from young HLS animals,
resveratrol had no protective, or detrimental, effects on muscles from young animals. In
aged gastrocnemius muscles, twenty-one days of resveratrol administration was
effective at reducing both hydrogen peroxide (H2O2)
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concentrations and oxidative damage in the form of lipid peroxidation (Figure 2.3) in
muscles exposed to HLS. These reductions in oxidative stress indices coincided with
the fact that resveratrol enhanced the endogenous anti-oxidant system in the form of
increases in both MnSOD and catalase protein contents and enzymatic activities
(Figure 2.2). Although not addressed in chapter 2, increases in MnSOD and catalase
activity were likely mediated by resveratrols ability to upregulate Sirt1 in gastrocnemius
muscles from aged animals (Figure 4.1), given that resveratrol has been repeatedly
shown to upregulate endogenous antioxidant enzymes in a Sirt1-FOXO dependent
manner (as discussed in Chapter 1).

Figure 4.1- Sirtuin 1 protein content in gastrocnemius muscles. Gastrocnemius muscles from young and
aged animals exposed to 21 days of resveratrol administration (12.5mg/kg/day) and 14 days of hindlimb suspension.
YC= Young Control, YS = Young Suspended, OC = Old Control, OS = Old Suspended, YVC = Young Vehicle
Control, YVCS = Young Vehicle Control Suspended, YRC = Young Resveratrol Control, YRS = Young
Resveratrol Suspended, OVC = Old Vehicle Control, OVCS = Old Vehicle Control Suspended, ORC = Old
Resveratrol Control, ORS = Old Resveratrol Suspended. **p ≤ 0.05, non-suspended control vs. suspended
animals (Suspension effect). # p ≤ 0.05, old vs. young treatment matched (Aging effect). *p ≤ 0.05, vehicle control vs.
age-matched and treatment matched groups (Effect of resveratrol).
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Despite reductions in pro-apoptotic signaling and the upregulation of the antiapoptotic protein Bcl-2 (Figure 2.5), resveratrol administration was not an effective
countermeasure to disuse-mediated increases in apoptotic signaling in aged skeletal
muscle. However, in terms of the functional outcomes the results were quite promising.
Resveratrol administration was effective in preserving the relative ratio of muscle mass
to body mass and significantly attenuated the loss of maximal isometric force in aged
plantarflexor muscles following HLS (Figure 2.5). Similarly to both, indices of oxidative
stress and apoptosis this protective effect of resveratrol was age dependent and only
present in aged animals. To the author’s knowledge this is the first study presenting
data that shows a clear differential effect of resveratrol in skeletal muscle that is
dependent upon the age of the animal. The overall results of the study indicate that
resveratrol has the potential to be a therapeutic agent, likely through a pharmacological
pre-conditioning effect that acts to upregulate the endogenous anti-oxidant enzyme
system potentiating the system to be able to handle the increased oxidant load that is
present in acute conditions of muscle wasting.
Sarcopenia progression in long-term resveratrol supplemented animals.
Given the fact that acute resveratrol supplementation was effective at reducing
oxidative stress and preserving relative muscle mass and function in aged skeletal
muscle following disuse-mediated atrophy, the second study in this dissertation sought
to ascertain if long-term dietary supplementation with resveratrol would reduce the
chronic basal levels of oxidative stress that are often found in aged skeletal muscle. My
hopes were that by reducing oxidative stress over a long period of time, resveratrol
could potentially slow the progression of sarcopenia. Additionally, in light of the fact that
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resveratrol was able to upregulate Sirt1 following acute administration (figure 4.1), the
second study aimed to clarify if upregulation of Sirt1 by resveratrol over prolonged
periods would affect mitochondrial signaling, as measured by PGC1 signaling which is a
known target of Sirt1 (as discussed in chapter 1)
Muscles from aged (28mo) mice weighed significantly less than muscles from
either young (6mo), or middle-aged mice (18mo), even when normalized to body weight
confirming the notion that with advanced age there is a progressive loss of muscle mass
(Figure 3.1). Counter to what was hypothesized, long-term (10mo) dietary
supplementation with resveratrol was unable to attenuate sarcopenia in either
gastrocnemius or plantaris muscles (Table 3.1). Despite the lack of preservation of
muscle mass seen in supplemented animals, dietary resveratrol supplementation was
effective in reducing indices of oxidative stress including reduction of H2O2 levels and
lipid peroxidation levels (Figure 3.4). In congruence with the effects of resveratrol on
aged muscle from HLS animals, long-term resveratrol supplementation effectively
upregulated MnSOD activity and decreased CuZnSOD activity. Presumably these
results are due to the interplay of increased MnSOD activity effectively reducing H2O2
concentrations and in turn the reduction in H2O2 levels are likely responsible for the
reductions in CuZnSOD activity which is known to become upregulated in response to
oxidant load.
Although not addressed in the main body of chapter two, markers of apoptotic
signaling and DNA fragmentation were assessed in vastus lateralis muscles to
determine if reductions in oxidative stress would results in a reduction in the
translocation of the pro-apoptotic Bax to the mitochondrial membrane. As discussed at
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length in chapter 1, this translocation is initiated by an oxidant-sensitive conformational
change in the Bax protein that allows Bax to disassociate from the anti-apoptotic protein
Bcl-2 in the cytoplasm. This leaves Bax free to translocate to the outer-mitochondrial
membrane and initiate pore formation leading to an eventual loss of mitochondrial
membrane integrity, the end result being a release of cytochrome c and eventual
apoptosis. Long-term resveratrol supplementation was not effective in reducing the
translocation of Bax to the mitochondria, nor was it effective in reducing the total
cytosolic protein content of Bax (Figure 4.2). Moreover, unlike the results from the acute
administration of resveratrol, long-term supplementation with resveratrol was unable to
increase the anti-apoptotic Bcl-2 protein (Figure 4.2) or lower caspase 3 activity (Figure
4.3).

Figure 4.2- The subcellular localization of Bax and Bcl-2. Vastus lateralis muscles were fractionated into a
mitochondrial pellet and a mitochondria-free cytosolic fraction for assessment of the subcellular localization of the
pro-apoptotic Bax protein and the anti-apoptotic Bcl-2 protein. A. Immunblot analysis of Bax protein content. Data are
expressed as a measure of optical density and a representative ponceau stain is displayed as qualitative assurance
of equal protein loading. B. Immunblot analysis of Bcl-2 protein content. Data are expressed as a measure of optical
density and a representative ponceau stain is displayed as qualitative assurance of equal protein loading. YC =
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young control, MAC = middle-aged control AC = aged control AR = aged resveratrol supplemented.
Significance was set at (p ≤ 0.05) and all data are presented as mean ± standard error. # p ≤ 0.05, young control
(Aging Effect).

Figure 4.3- Apoptotic Signaling: Apoptotic indices were measured in vastus lateralis muscles. A. A fluorescent
enzyme activity assay was used to assess the activity of the executioner caspase, caspase 3, within vastus lateralis
muscle homogenate. The data are presented as normalized fluorescent intensity. B. An ELISA quantifying DNA
fragmentation was implemented to estimate the levels of apoptosis, within vastus lateralis muscles. The results are
represented as normalized optical density readings and are linearly related to the amount of fragmented DNA present
in the muscle homogenate. YC = young control, MAC = middle-aged control AC = aged control AR = aged
resveratrol supplemented. Significance was set at (p ≤ 0.05) and all data are presented as mean ± standard error.
# p ≤ 0.05, young control (Aging Effect).

Not surprisingly then, there was no attenuation of DNA fragmentation (Figure
4.3), the hallmark of apoptosis, by long-term resveratrol supplementation. These data
highlight the differences between acute and long-term exposure to resveratrol and also
suggest that a perturbation may be necessary (i.e. muscle disuse) in order to observe
any protective effective that is attributable to resveratrol supplementation. Furthermore,
the results of the dissertation as whole bring into question the assumed linear
relationship that is often thought to exist between oxidative stress and apoptosis. It
seems more likely that the increases in oxidative stress and apoptotic signaling that
occur with both advanced age and muscle wasting conditions are concomitant
conditions that although may be correlated are not casual to each other.
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Sirt1 activity was modestly upregulated following ten months of dietary
resveratrol supplementation (Figure 3.1). Unfortunately, this augmented Sirt1 activity did
not translate to increased citrate synthase activity, PGC1 protein content or improved
mitochondrial membrane integrity. It was hypothesized that through the upregulation of
Sirt1 and subsequently PGC1, skeletal muscles from supplemented animals would
display enhanced resistance to muscle fatigue. This hypothesis was rejected since
plantaris muscles from aged supplemented animals did not show any resistance to
muscle fatigue (figure 3.6), it should be noted that muscle fatigue was measured ex vivo
and therefore these data were unable to take into account neuronal, and/or systemic
factors that can contribute to muscle fatigue. Furthermore, plantaris muscles from
supplemented animals displayed a rightward shift of their force-frequency curves
indicative of a faster muscle profile, a direct contrast to what one would expect from a
muscle that had undergone a metabolic shift to a more oxidative state.
Although others have shown that resveratrol’s ability to activate Sirt1 leads to a
PGC1-mediated enhancement of oxidative metabolism, muscle fatigue resistance and
mitochondrial biogenesis, our results do not corroborate a relationship between Sirt1
upregulation and PGC1 signaling. This may be due in part to the wide range of
dosages, treatment durations and modalities of resveratrol administration present in the
current body of literature. The results of this dissertation suggest that the capacity of
resveratrol to protect skeletal muscle from increases in oxidative stress and
consequently oxidative damage likely resides in resveratrols ability to activate Sirt1 and
via this upregulation enhance components of the endogenous anti-oxidant system. It
also would seem that increases in oxidative stress can influence muscle mass and
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function, but they are not causative factors mediating apoptosis in skeletal muscle. It is
also possible, given that resveratrol has been shown to be an effective antiinflammatory agent, that reductions in inflammation within aged skeletal muscle lessen
the effects of exogenous stressors and therefore improve the outcomes of muscle
following atrophy-mediating events. Further work is needed to determine if resveratrol
has the potential to be an effective therapeutic agent to treat muscle functional
decrements associated with chronic elevated oxidative stress in aged individuals.
However, its effectiveness as a pharmacological pre-conditioner in response to acute
stress seems to be better established and appears to be the result of improving the
redox status associated with atrophic conditions.

Future directions and recommendations:
Upcoming studies that seek to further understand of the molecular effects of
resveratrol on skeletal muscle may be better served to focus on pathways outside of the
oxidative stress-apoptosis continuum and perhaps investigate in more detail the Sirt1dependent effects that resveratrol can have on stress resistance (i.e. FOXO mediated
upregulation of MnSOD and Catalase) and mitochondrial signaling. Furthermore, given
the relative importance of insulin like growth factor (IGF-1) and mammalian target of
rapamycin (mTOR) signaling with regard to muscle protein synthesis it would also be
interesting and prudent to evaluate the effects, if any, that resveratrol and Sirt1 signaling
may have with regard to this metabolic signaling network, given that Sirt1 is a powerful
modulator of many metabolic pathways including insulin signaling. Although the current
experimental protocol did not elicit enhanced PGC1 signaling, this is likely due to the
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dosage and modality of supplementation. Other investigators have shown successful
augmentation of mitochondrial biogenesis and improved oxidative capacity in skeletal
muscle from rodents receiving dietary resveratrol supplementation that was prepared in
a high fat medium. Given that resveratrol, is fat soluble, the lack of increased fat content
in our dietary model may have prevented maximal absorption of the compound and
could explain the failure of resveratrol to bring about an increase in PGC1 signaling in
the current study. Therefore if the chosen route of resveratrol exposure is going to be
dietary, the chow should be made with a higher fat content.
To better determine if resveratrol protects against increased oxidative stress by
both augmenting the antioxidant defense system and enhancing mitochondrial
biogenesis, more exact measures to quantify mitochondrial function and content should
be used. Fluorescent activated cell sorting analysis could be employed to more directly
measure mitochondrial density, size and internal complexity, electron transport chain
respiratory capacity to quantify mitochondrial capacity and mitochondrial membrane
potential (ΔΨm) could be measured by flow cytometry using the ratiometric dye
5,5’,6,6’-tetrachloro-1,1’,3,3’ tetraethylbenzimidazol carbocyanine iodide (JC-1;
Molecular Probes, Carlsbad, CA). Additionally, pinpointing the source of ROS from the
mitochondria could be obtained concomitantly to mitochondrial respiratory
measurements by using the oxidation-dependent compound, dihydroethidium, to
measure intracellular levels of O2●– and ROS in isolated mitochondria by flow cytometry.
With regard to skeletal muscle form and function it would be both novel and beneficial to
measure the effects of resveratrol on muscle fiber composition and cross-sectional
area. To date the literature has only established the effects of resveratrol
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supplementation on skeletal muscle enzyme composition and muscle wet weight.
There are also several Sirt1 transgenic models to choose from that may prove to be
more exact in delineating the exact molecular signaling pathways that Sirt1 targets and
thus further the understanding of the potential therapeutic role(s) that resveratrol may
fulfill.
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